## Patent Reference

- Title: A method to distinguish diseased embryos from normal embryos with CNV microdeletion microduplication syndrome
- URL: https://patents.google.com/patent/CN114480611A/en

### Abstract

Abstract The invention relates to a method for identifying diseased embryos and normal embryos of CNV microdeletion and microdropping syndrome. The present invention is in the field of genetic diagnosis and assisted reproduction by humans, and more particularly, relates to the technology of pre-implantation detection of embryos (PGT). According to the method, family haplotype linkage analysis is carried out on a patient with Copy Number Variation (CNV) microdeletion microreplication syndrome, a spouse thereof, an embryo after in vitro fertilization and a chromosome of a patient relative or a fetal tissue suffering from CNV microdeletion microreplication syndrome, so that a sick embryo and a normal embryo carrying CNV can be rapidly, simply and accurately distinguished, and the chromosome aneuploidy of the embryo is screened at the same time, thereby improving the clinical pregnancy rate, realizing timely detection of the sick embryo before embryo transplantation, transplantation of the non-sick embryo, prevention of birth of a defective child and timely blocking the genetic transmission of the CNV microdeletion microreplication syndrome disease to the next generation. Promoting the development and progress of human assisted reproductive technology to a certain extent.

### Description

Description Translated from Chinese 一种鉴别CNV微缺失微重复综合征患病胚胎和正常胚胎的 方法A method for distinguishing diseased embryos from normal embryos with CNV microdeletion and microduplication syndrome 技术领域technical field 本发明属于CNV微缺失微重复综合征疾病诊断和人类辅助生殖领域，具体而言，涉及胚胎植入前遗传学检测技术(PGT)，是一种能够鉴别胚胎是否遗传亲本CNV所在染色体遗传信息的核心家系单体型连锁分析方法。The invention belongs to the field of CNV microdeletion and microduplication syndrome disease diagnosis and human assisted reproduction, in particular to the preimplantation genetic testing technology (PGT) of embryos, which is a method capable of identifying whether embryos inherit the chromosomal genetic information of the parental CNV. Haplotype linkage analysis method in nuclear family. 背景技术Background technique 拷贝数变异(Copy number variation,CNV)一般是指长度大于1kb的基因组片段的缺失或重复，主要表现为染色体亚显微水平的结构变异。人类基因组中有约12％的区域易于发生CNV。在正常健康人群中，CNV总共占基因组的18％，绝大部分为良性CNV，其他CNV可为致病性CNV和不确定CNV。CNV也可导致基因剂量的改变，或打断基因，使基因发生破坏或融合，还可构成复合杂合，使隐性变异显性化。2004年CNV被首次发现导致出生缺陷等重大疾病，预测CNV与15％的人类遗传病相关联。CNV是造成自然流产和出生缺陷(致死)的重要遗传因素，在智力发育障碍和自闭症等神经系统异常中尤其扮演重要角色。Copy number variation (CNV) generally refers to the deletion or duplication of genomic fragments greater than 1 kb in length, mainly manifesting as structural variation at the submicroscopic level of chromosomes. About 12% of the human genome is prone to CNVs. In normal healthy people, CNVs account for a total of 18% of the genome, the vast majority are benign CNVs, and other CNVs can be pathogenic CNVs and uncertain CNVs. CNVs can also lead to changes in gene dosage, or interrupt genes, causing gene disruption or fusion, and can also constitute compound heterozygosity, making recessive variants dominant. CNV was first discovered in 2004 to cause major diseases such as birth defects, and CNV is predicted to be associated with 15% of human genetic diseases. CNV is an important genetic cause of spontaneous abortion and birth defects (death), and plays a particularly important role in neurological abnormalities such as intellectual developmental disabilities and autism. 胚胎植入前遗传学检测(Preimplantation genetic testing，PGT)是一种针对于遗传风险较高患者的ART技术，是指精子与卵子在体外结合形成受精卵发育成胚胎后，在植入到母体子宫之前对胚胎进行的基因检测或染色体异常的检测，挑选不患病的胚胎再进行移植。PGT技术根据检测目的不同，可分为三类，包括胚胎植入前非整倍体检测(Preimplantation genetic testing foraneuploidy，PGT-A)，胚胎植入前单基因病检测(Preimplantation genetic testing for monogenic，PGT-M)，胚胎植入前染色体结构重排检测(PGT-SR)。PGT最早由英国科学家Handyside AH首先成功应用于临床，最初的PGT技术使用PCR或FISH方法检测性别，帮助有风险生育血友病A、进行性肌营养不良等X连锁遗传病后代的夫妇妊娠分娩出正常女婴；近年来，随着基因芯片技术和测序技术的快速发展，PGT技术可以对胚胎中的23对染色体全面进行筛查，检测胚胎中的非整倍体，和大片段的缺失重复，提高临床妊娠率，目前在辅助生殖领域得到广泛的应用。尽管如此，上述PGT遗传检测技术仍有一定的局限性，由于对检测样本量的需求较大，而胚胎无法提供足够上述检测所需的样本量，因此上述PGT技术一般只能检测3-5Mb以上的CNV，对于小片段的CNV微缺失微重复无法准确检测。对于这些具有已知的CNV综合征的夫妇，目前还没有十分有效的检测技术能够在胚胎期准确判断待植入胚胎是CNV综合征患病胚胎还是正常胚胎。Preimplantation genetic testing (PGT) is an ART technology for patients with high genetic risk. Genetic testing or chromosomal abnormalities previously performed on embryos to select embryos that are not diseased for transfer. PGT technology can be divided into three categories according to different detection purposes, including preimplantation genetic testing for aneuploidy (PGT-A), preimplantation genetic testing for monogenic disease (PGT) -M), Preimplantation Chromosomal Structural Rearrangement Detection (PGT-SR). PGT was first successfully used in clinical practice by British scientist Handyside AH. The initial PGT technology used PCR or FISH to detect gender, helping couples at risk of having children with X-linked genetic diseases such as hemophilia A and progressive muscular dystrophy to conceive and give birth. Normal baby girl; in recent years, with the rapid development of gene chip technology and sequencing technology, PGT technology can comprehensively screen 23 pairs of chromosomes in embryos, detect aneuploidy in embryos, and large deletions and duplications, It is widely used in the field of assisted reproduction to improve the clinical pregnancy rate. Nonetheless, the above-mentioned PGT genetic testing techniques still have certain limitations. Due to the large demand for testing samples, and embryos cannot provide enough samples for the above-mentioned tests, the above-mentioned PGT techniques can generally only detect more than 3-5Mb. The CNV of small fragments of CNV microdeletions and microduplications cannot be accurately detected. For these couples with known CNV syndrome, there is currently no very effective detection technology that can accurately determine whether the embryo to be implanted is a CNV syndrome diseased embryo or a normal embryo at the embryonic stage. 发明内容SUMMARY OF THE INVENTION 针对上述现有技术中存在的缺陷，本发明建立了一种在植入前鉴别胚胎是CNV综合征患病胚胎还是正常胚胎的PGT技术。In view of the above-mentioned defects in the prior art, the present invention establishes a PGT technology for identifying whether an embryo is a CNV syndrome diseased embryo or a normal embryo before implantation. 本发明的具体技术方案如下：The concrete technical scheme of the present invention is as follows: 第一方面，本发明提供一种用于鉴别CNV微缺失微重复综合征患病胚胎和正常胚胎的家系单体型构建方法，包含以下步骤：In the first aspect, the present invention provides a family haplotype construction method for identifying CNV microdeletion microduplication syndrome diseased embryos and normal embryos, comprising the following steps: 1)样本基因分型：将CNV微缺失微重复综合征患者夫妇双方、和至少一名患者亲属进行大规模SNP基因型检测；将患者夫妇双方和患者亲属称为参照样本；优选地，所述患者亲属可选自患者的父母、子女、兄弟姐妹，或患有CNV微缺失微重复综合征的患者夫妇流产、引产或活产胎儿组织；所述患者亲属优先选择流产、引产或活产的患病胎儿，也可选择其他患者亲属；更优选地，所述患者亲属可选自同样患有CNV微缺失微重复综合征的亲属，也可选自染色体正常的亲属；1) Sample genotyping: perform large-scale SNP genotyping on both the couple and at least one relative of the patient with CNV microdeletion and microduplication syndrome; both the couple and the patient's relative are referred to as reference samples; preferably, the The patient's relatives can be selected from the patient's parents, children, siblings, or the patient's couple with CNV microdeletion microduplication syndrome who have abortion, induced labor or live birth fetal tissue; For the sick fetus, other relatives of the patient can also be selected; more preferably, the relatives of the patient can be selected from relatives who also suffer from CNV microdeletion and microduplication syndrome, and can also be selected from relatives with normal chromosomes; 2)确定信息SNPs位点：信息SNPs的选择标准为：在CNV微缺失微重复综合征患者中为杂合型，在其配偶中为纯合型，并且在患者亲属中也是纯合型的SNP位点；选择覆盖CNV断裂点、CNV所在染色体和与其相对应的正常的同源染色体上的信息SNPs，染色体每Mb范围内至少选择1个信息SNP；在覆盖CNV断裂点区域，信息SNPs从断裂点上下游1-5Mb范围内选择，优选自1-3Mb范围内选择；2) Identify informative SNPs loci: The selection criteria for informative SNPs are: SNPs that are heterozygous in CNV microdeletion-microduplication syndrome patients, homozygous in their spouses, and homozygous in relatives of patients Site; select the informative SNPs covering the CNV breakpoint, the chromosome where the CNV is located, and its corresponding normal homologous chromosome, and at least one informative SNP is selected within each Mb range of the chromosome; in the area covering the CNV breakpoint, the informative SNPs are derived from the Select from the range of 1-5Mb upstream and downstream, preferably from the range of 1-3Mb; 3)构建家系单体型：集合步骤2)确定的信息SNPs位点通过家系连锁分析得到覆盖CNV两个断裂点区域、CNV所在整条染色体及其同源染色体的整条染色体的单体型，不同染色体单体型的集合称为家系单体型。3) Constructing the family haplotype: collecting the information SNPs determined in step 2) through family linkage analysis to obtain the haplotype covering the two breakpoint regions of the CNV, the entire chromosome where the CNV is located and the entire chromosome of its homologous chromosome, A collection of different chromosomal haplotypes is called a familial haplotype. 第二方面，本发明提供一种用于鉴别CNV微缺失微重复综合征患病胚胎和正常胚胎的家系单体型的构建系统，所述系统包含能够计算处理样本数据的软件、和用于承载上述软件的硬件：In a second aspect, the present invention provides a construction system for identifying pedigree haplotypes of CNV microdeletion microduplication syndrome diseased embryos and normal embryos, the system comprising software capable of computing and processing sample data, and a system for carrying Hardware for the above software: 1)所述系统还包含储存有CNV微缺失微重复综合征患者夫妇双方、和至少一名患者亲属进行大规模SNP基因型检测的基因分型数据的硬件；将患者夫妇双方和患者亲属称为参照样本；优选地，所述患者亲属可选自患者的父母、子女、兄弟姐妹，或患有CNV微缺失微重复综合征的患者夫妇流产、引产或活产胎儿组织；所述患者亲属优先选择流产、引产或活产的患病胎儿，也可选择其他患者亲属；更优选地，所述患者亲属可选自同样患有CNV微缺失微重复综合征的亲属，也可选自染色体正常的亲属；1) The system also includes hardware that stores the genotyping data for large-scale SNP genotyping testing performed by both the couple and at least one relative of the patient with CNV microdeletion and microduplication syndrome; Reference sample; preferably, the patient's relatives can be selected from the patient's parents, children, siblings, or the patient's couple with CNV microdeletion microduplication syndrome abortion, induced labor or live birth fetal tissue; the patient's relatives are preferred Aborted, induced or live-born sick fetuses, other relatives of patients can also be selected; more preferably, the relatives of patients can be selected from relatives who also suffer from CNV microdeletion and microduplication syndrome, and can also be selected from relatives with normal chromosomes ; 2)所述软件根据下述规则确定信息SNPs位点：信息SNPs的选择标准为：在CNV微缺失微重复综合征患者中为杂合型，在其配偶中为纯合型，并且在患者亲属中也是纯合型的SNP位点；选择覆盖CNV断裂点、CNV所在染色体和与其相对应的正常的同源染色体上的信息SNPs，染色体每Mb范围内至少选择1个信息SNP；在覆盖CNV断裂点区域，信息SNPs从断裂点上下游1-5Mb范围内选择，优选自1-3Mb范围内选择；2) The software determines the information SNPs loci according to the following rules: the selection criteria of the information SNPs are: heterozygous in CNV microdeletion microduplication syndrome patients, homozygous in their spouses, and in the relatives of the patients. It is also a homozygous SNP site in CNV; select informative SNPs covering the CNV breakpoint, the chromosome where the CNV is located, and its corresponding normal homologous chromosome, and at least 1 informative SNP within each Mb range of the chromosome; In the dot area, the information SNPs are selected from the range of 1-5Mb upstream and downstream of the breakpoint, preferably from the range of 1-3Mb; 3)构建家系单体型：集合步骤2)确定的信息SNPs位点通过家系连锁分析得到覆盖CNV两个断裂点区域、CNV所在整条染色体及其同源染色体的整条染色体的单体型，不同染色体单体型的集合称为家系单体型。3) Constructing the family haplotype: collecting the information SNPs determined in step 2) through family linkage analysis to obtain the haplotype covering the two breakpoint regions of the CNV, the entire chromosome where the CNV is located and the entire chromosome of its homologous chromosome, A collection of different chromosomal haplotypes is called a familial haplotype. 第三方面，本发明提供一种用于鉴别CNV微缺失微重复综合征患病胚胎和正常胚胎的系统，所述系统包含能够计算处理样本数据的软件、和用于承载上述软件的硬件，In a third aspect, the present invention provides a system for identifying CNV microdeletion microduplication syndrome diseased embryos and normal embryos, the system comprising software capable of computing and processing sample data, and hardware for carrying the above software, 1)所述系统还包含储存有CNV微缺失微重复综合征患者夫妇双方、至少一名患者亲属和CNV微缺失微重复综合征患者夫妇体外受精胚胎进行大规模SNP基因型检测的基因分型数据的硬件；将患者夫妇双方和患者亲属称为参照样本；优选地，所述患者亲属可选自患者的父母、子女、兄弟姐妹，或患有CNV微缺失微重复综合征的患者夫妇流产、引产或活产胎儿组织；所述患者亲属优先选择流产、引产或活产的患病胎儿，也可选择其他患者亲属；更优选地，所述患者亲属可选自同样患有CNV微缺失微重复综合征的亲属，也可选自染色体正常的亲属；1) The system also includes stored genotyping data for large-scale SNP genotyping of both couples of a patient with CNV microdeletion and microduplication syndrome, at least one relative of the patient, and in vitro fertilization embryos of a couple of a patient with CNV microdeletion and microduplication syndrome The hardware of the patient's couple and the patient's relatives are referred to as reference samples; preferably, the patient's relatives can be selected from the patient's parents, children, siblings, or the patient's couple with CNV microdeletion and microduplication syndrome. Abortion, induction of labor Or the tissue of a live-born fetus; the relatives of the patient are preferentially selected for miscarriage, induced labor or live-born diseased fetuses, and other relatives of the patient can also be selected; more preferably, the relatives of the patient can be selected from the same group of patients suffering from CNV microdeletion and microduplication syndrome The relatives of the phenotype can also be selected from relatives with normal chromosomes; 2)所述软件根据下述规则确定信息SNPs位点：信息SNPs的选择标准为：在CNV微缺失微重复综合征患者中为杂合型，在其配偶中为纯合型，并且在患者亲属中也是纯合型的SNP位点；选择覆盖CNV断裂点、CNV所在染色体和与其相对应的正常的同源染色体上的信息SNPs，染色体每Mb范围内至少选择1个信息SNP；在覆盖CNV断裂点区域，信息SNPs从断裂点上下游1-5Mb范围内选择，优选自1-3Mb范围内选择；2) The software determines the information SNPs loci according to the following rules: the selection criteria of the information SNPs are: heterozygous in CNV microdeletion microduplication syndrome patients, homozygous in their spouses, and in the relatives of the patients. It is also a homozygous SNP site in CNV; select informative SNPs covering the CNV breakpoint, the chromosome where the CNV is located, and its corresponding normal homologous chromosome, and at least 1 informative SNP within each Mb range of the chromosome; In the dot area, the information SNPs are selected from the range of 1-5Mb upstream and downstream of the breakpoint, preferably from the range of 1-3Mb; 3)构建家系单体型：集合步骤2)确定的信息SNPs位点通过家系连锁分析得到覆盖CNV两个断裂点区域、CNV所在整条染色体及其同源染色体的整条染色体的单体型，不同染色体单体型的集合称为家系单体型；3) Constructing the family haplotype: collecting the information SNPs determined in step 2) through family linkage analysis to obtain the haplotype covering the two breakpoint regions of the CNV, the entire chromosome where the CNV is located and the entire chromosome of its homologous chromosome, A collection of different chromosomal haplotypes is called a family haplotype; 4)所述软件将待定样本中染色体单体型信息(基因分析数据)和家系单体型中参照样本的单体型信息(基因分型数据)进行比对，着重关注家系单体型中CNV断裂点区域的单体型信息，通过整条染色体的单体型信息判断染色体易位断裂点区域是否发生了同源重组：4) The software compares the haplotype information (gene analysis data) in the undetermined sample with the haplotype information (genotyping data) of the reference sample in the family haplotype, focusing on CNV in the family haplotype The haplotype information of the breakpoint region is used to determine whether homologous recombination has occurred in the chromosomal translocation breakpoint region based on the haplotype information of the entire chromosome: i)当以与CNV微缺失微重复综合征患者具有相同疾病的亲属为参照时：i) When referring to relatives with the same disease as a patient with CNV microdeletion microduplication syndrome: a.若待定样本的染色体对应于家系单体型中CNV断裂点的区域没有发生重组，当待定样本该区域单体型信息和CNV综合征患者以及与患者具有相同疾病亲属的单体型信息一致时，则为CNV综合征患病胚胎；当待定样本该区域单体型信息和参照样本中CNV综合征患者一致，但与患者具有相同疾病亲属的单体型信息不一致时，则为不患CNV综合征的正常胚胎；a. If the chromosome of the undetermined sample does not recombine in the region corresponding to the CNV breakpoint in the family haplotype, when the haplotype information of the undetermined sample is consistent with the haplotype information of the CNV syndrome patient and relatives with the same disease as the patient When the haplotype information of the undetermined sample is consistent with the CNV syndrome patient in the reference sample, but inconsistent with the haplotype information of the patient with the same disease relatives, it is not suffering from CNV Syndromic normal embryos; b.若待定样本的染色体对应于家系单体型中CNV断裂点的区域发生了同源重组，则判断标准与i)a相反；b. If homologous recombination occurs in the chromosome of the undetermined sample corresponding to the CNV breakpoint in the family haplotype, the judgment standard is opposite to i)a; ii)当以CNV正常(不患CNV综合征)的亲属为参照时：ii) When referring to relatives with normal CNV (without CNV syndrome): a.若待定样本的染色体对应于家系单体型中CNV断裂点的区域没有发生重组，当待定样本该区域单体型信息和参照样本中CNV综合征患者以及与CNV正常不患CNV综合征的亲属的单体型信息一致时，则为不患CNV综合征的正常胚胎；当待定样本该区域单体型信息和参照样本中CNV综合征患者一致，但与CNV正常不患CNV综合征的亲属的单体型信息不一致时，则为CNV综合征患病胚胎；a. If there is no recombination in the region of the chromosome of the undetermined sample corresponding to the CNV breakpoint in the family haplotype, when the haplotype information in the region of the undetermined sample and the CNV syndrome patients in the reference sample and those with normal CNV without CNV syndrome When the haplotype information of the relatives is consistent, it is a normal embryo without CNV syndrome; when the haplotype information in the region of the pending sample is consistent with the CNV syndrome patient in the reference sample, but it is with normal CNV relatives without CNV syndrome When the haplotype information is inconsistent, it is a CNV syndrome diseased embryo; b.若待定样本的染色体对应于家系单体型中CNV断裂点的区域发生了同源重组，则判断标准与ii)a相反。b. If homologous recombination occurs in the chromosome of the undetermined sample corresponding to the CNV breakpoint in the family haplotype, the judgment standard is opposite to ii)a. 在本发明的一些具体实施方式中，上述第一至三方面中，步骤1)所述大规模SNP基因型检测覆盖23对染色体；大规模SNP基因型检测方法优选基因芯片和基因测序。In some specific embodiments of the present invention, in the above first to third aspects, the large-scale SNP genotype detection in step 1) covers 23 pairs of chromosomes; the large-scale SNP genotype detection method is preferably gene chip and gene sequencing. 在本发明的一些具体实施方式中，上述第一至三方面中，CNV微缺失微重复综合征患者夫妇、患者的父母、子女、兄弟姐妹的检测样本来源为体细胞，优选外周血；胎儿样本可来源于流产或引产胎儿的皮肤组织、绒毛组织，也可以来源于活产患病胎儿的外周血组织。In some specific embodiments of the present invention, in the above-mentioned first to third aspects, the source of the detection samples of the couples of CNV microdeletion microduplication syndrome patients, the parents, children, and siblings of the patients is somatic cells, preferably peripheral blood; fetal samples; It can be derived from the skin tissue and villus tissue of an aborted or induced fetus, or from the peripheral blood tissue of a live-born sick fetus. 在本发明的一些具体实施方式中，上述第一至三方面中，在覆盖染色体易位断裂点区域，信息SNPs从染色体易位断裂点上下游2-4Mb范围内选择，优选从2Mb范围内选择。In some specific embodiments of the present invention, in the first to third aspects above, in the region covering the chromosomal translocation breakpoint, the informative SNPs are selected from the range of 2-4Mb upstream and downstream of the chromosomal translocation breakpoint, preferably from the range of 2Mb . 在本发明的一些具体实施方式中，上述第一至三方面中，步骤2)中染色体每Mb范围内至少选择2、3、4、5、6、7、8、9或10个信息SNPs。In some specific embodiments of the present invention, in the first to third aspects above, in step 2), at least 2, 3, 4, 5, 6, 7, 8, 9 or 10 informative SNPs are selected within each Mb range of the chromosome. 在本发明的一些具体实施方式中，上述第一至三方面中，胚胎发育至第3-7天时，活检获取1-10个细胞作为步骤1)中所述体外受精胚胎的检测样本；优选来源于胚胎卵裂球活检或囊胚滋养外胚层活检的细胞。In some specific embodiments of the present invention, in the first to third aspects above, when the embryo develops to the 3rd-7th day, 1-10 cells are obtained by biopsy as the detection sample of the in vitro fertilized embryo described in step 1); preferred source Cells from embryo blastomere biopsy or blastocyst trophectoderm biopsy. 在本发明的一些具体实施方式中，上述第一至三方面中，将活检获取的细胞裂解，进行全基因组扩增；全基因组扩增方法可选自MDA方法、MALBAC方法、或其他全基因组扩增方法。In some specific embodiments of the present invention, in the above-mentioned first to third aspects, the cells obtained from the biopsy are lysed, and whole genome amplification is performed; the whole genome amplification method can be selected from the MDA method, the MALBAC method, or other whole genome amplification methods. increase method. 附图说明Description of drawings 图1.1号家系遗传图谱。Figure 1.1 Genetic map of family No. 1. 图2.1号家系中患者的CNV微缺失检测结果。Figure 2. Results of CNV microdeletion testing for patients in family No. 1. 图3.1号家系参照样本和活检胚胎的CNV微缺失微重复综合征区域单体型分析结果。Figure 3. Results of haplotype analysis of the CNV microdeletion-microduplication syndrome region in reference samples and biopsied embryos of family No. 1. 图4.1号家系胚胎移植后在孕中期羊水穿刺染色体核型检测结果。Figure 4. Results of amniocentesis karyotype in the second trimester after embryo transfer in family No. 1. 图5.1号家系胚胎移植后在孕中期羊水穿刺CNV检测结果(正常)。Figure 5. Results of CNV test by amniocentesis in the second trimester of family No. 1 after embryo transfer (normal). 具体实施方式Detailed ways 实施例1：患者及患者亲代的参照样本收集Example 1: Collection of reference samples from patients and their parents 募集了3个将接受辅助生殖的CNV微缺失微重复综合征的患者，入选者均来自复旦大学附属妇产科医院上海集爱遗传与不育诊疗中心。每个家庭都需要签署书面知情同意书，研究方案由复旦大学妇产科医院上海集爱遗传与不育诊疗中心人类受试者伦理委员会批准。Three patients with CNV microdeletion and microduplication syndrome who will receive assisted reproduction were recruited. All selected were from Shanghai Ji'ai Genetics and Infertility Clinic, Obstetrics and Gynecology Hospital Affiliated to Fudan University. Each family was required to sign a written informed consent, and the study protocol was approved by the Human Subjects Ethics Committee of Shanghai Ji'ai Genetics and Infertility Clinic, Fudan University Obstetrics and Gynecology Hospital. 从2020年9月到2021年6月，所有家庭都有不良孕产的历史，患有CNV微缺失微重复综合征夫妇一方在后文中简称为“患者”，另一方简称“患者配偶”，家系图谱示意请见图1。在募集的同时抽取每对患者夫妇和患者亲属(所述患者亲属可选自患者的父母、子女、兄弟姐妹，或患有CNV微缺失微重复综合征的患者夫妇流产、引产或活产胎儿组织；胎儿组织可来源于流产或引产胎儿的皮肤组织、绒毛组织，也可以来源于活产患病胎儿的外周血组织；所述患者亲属优先选择流产、引产或活产的患病胎儿，也可选择其他患者亲属)的外周血10ml，按照本领域常规方式提取DNA，一部分用于CNV检测，一部分用于后续SNPs分型使用。From September 2020 to June 2021, all families had a history of adverse pregnancy and childbirth. One of the couples with CNV microdeletion and microduplication syndrome is hereinafter referred to as 'patient', and the other is referred to as 'patient's spouse'. Please see Figure 1 for a schematic diagram. At the time of recruitment, each patient couple and patient relatives (the patient relatives can be selected from the patient's parents, children, siblings, or patient couples with CNV microdeletion microduplication syndrome aborted, induced or live birth fetal tissue The fetal tissue can be derived from the skin tissue and villus tissue of the aborted or induced fetus, or from the peripheral blood tissue of the live-born sick fetus; the relatives of the patient preferentially choose the aborted, induced or live-born sick fetus, or Select 10 ml of peripheral blood from other patients' relatives), and extract DNA according to the conventional method in the art, part of which is used for CNV detection and part for subsequent SNPs typing. 使用Illumina微阵列基因芯片用于CNV检测方法如下：The method of using Illumina microarray gene chip for CNV detection is as follows: (1)实验前准备(1) Preparation before the experiment 1)个人防护：根据实验室安全防护相关程序内容，更换实验服、戴帽子、口罩、鞋套进入实验室。1) Personal protection: According to the relevant procedures of laboratory safety protection, change lab coats, wear hats, masks, and shoe covers to enter the laboratory. 2)紫外消毒：打开超净工作台内的紫外灯，杀菌30min，关闭紫外灯，打开风机，通风10min。2) UV disinfection: turn on the UV lamp in the ultra-clean workbench, sterilize for 30 minutes, turn off the UV lamp, turn on the fan, and ventilate for 10 minutes. 3)打印相关材料：基因芯片操作记录表、基因芯片上样登记表等。3) Printing related materials: gene chip operation record form, gene chip sample registration form, etc. 4)试剂盒准备：除基因芯片配套的试剂外，还需准备0.1M NaOH、异丙醇、甲酰胺、0.5M EDTA、去离子水、无水乙醇，操作需三天完成，当天实验前将要用到的冷冻试剂放置室温融化。4) Kit preparation: In addition to the reagents provided with the gene chip, 0.1M NaOH, isopropanol, formamide, 0.5M EDTA, deionized water, and absolute ethanol need to be prepared. The frozen reagents used are thawed at room temperature. 5)耗材准备：准备一个96深孔板及两块配套胶套，各种规格滤芯吸头，加样槽、小黄板等。5) Preparation of consumables: prepare a 96 deep-well plate and two matching rubber sleeves, filter tips of various specifications, sample addition tank, small yellow plate, etc. 6)样本准备：从-20℃冰箱中取出患者夫妇及其亲属样本，核实样本编号和记录单上编号是否一致，核实完毕，将样本涡旋瞬离后按记录单的上样顺序摆放。6) Sample preparation: Take the samples of the patient couple and their relatives from the -20°C refrigerator, and verify whether the sample number is consistent with the number on the record sheet. After verification, vortex the samples and place them in the order of loading on the record sheet. (2)配制MSA3(2) Preparation of MSA3 1)将MA1、MA2、MSM置于常温融化，融化后颠倒混匀，0.1M NaOH涡旋混匀。1) Melt MA1, MA2 and MSM at room temperature, invert and mix after melting, and vortex mix with 0.1M NaOH. 2)将样本从-20℃冰箱取出放在小黄板上，置于室温自然融化后涡旋瞬离，将样本按记录单上样顺序摆放好。2) Take the samples out of the -20°C refrigerator and place them on a small yellow plate, let them melt naturally at room temperature, and then vortex for instant separation. Place the samples in the order in which they were loaded on the record sheet. 3)按照样本数量N，在96深孔板上选取N个加样孔，做好标记。3) According to the number of samples N, select N sample wells on the 96-deep well plate and mark them well. 4)提前将杂交炉打开，温度调至37℃。4) Turn on the hybridization furnace in advance and adjust the temperature to 37°C. 5)用排枪吸取20μL的MA1加入到选好的96深孔板加样孔中。5) Pipette 20 μL of MA1 into the selected 96-deep-well plate sample wells with a spray gun. 6)用排枪吸取4μL的样本加入到对应的加样孔中。6) Pipet 4 μL of the sample into the corresponding sample well with the spray gun. 7)用排枪吸取4μL的0.1M NaOH加入到样本孔中，盖上胶套，1600rpm振荡1min，280xg离心1min后室温静置10min。7) Pipette 4 μL of 0.1M NaOH into the sample well with a discharge gun, cover with a rubber sleeve, shake at 1600 rpm for 1 min, centrifuge at 280×g for 1 min, and then stand at room temperature for 10 min. 8)用排枪吸取34μL的MA2加到样本孔中。8) Pipette 34 μL of MA2 into the sample well with a discharge gun. 9)用排枪吸取38μL的MSM加到样本孔中，盖上胶套，1600rpm振荡1min，280xg离心1min后37℃杂交炉孵育20-24h。9) Pipette 38 μL of MSM into the sample well with a discharge gun, cover with a plastic sleeve, shake at 1600 rpm for 1 min, centrifuge at 280×g for 1 min, and then incubate in a hybridization oven at 37°C for 20-24 h. (3)MSA3片段化(3) MSA3 fragmentation 1)将FMS置于常温融化，融化后颠倒混匀。1) Melt FMS at room temperature, invert and mix after melting. 2)提前打开金属浴，温度调至37℃。2) Open the metal bath in advance and adjust the temperature to 37°C. 3)将96深孔板从杂交炉取出，用排枪吸取25μL的FMS加入到样本孔中，盖上胶套，1600rpm振荡1min，280xg离心1min后金属浴1h。3) Take the 96-deep-well plate out of the hybridization oven, draw 25 μL of FMS into the sample wells with a row gun, cover with a plastic sleeve, shake at 1600 rpm for 1 min, centrifuge at 280×g for 1 min, and then metal bath for 1 h. (4)沉淀MSA3(4) Precipitation of MSA3 1)取出PM1、准备好异丙醇。1) Take out PM1 and prepare isopropanol. 2)提前打开冷冻离心机，设置温度为4℃进行预冷。2) Turn on the refrigerated centrifuge in advance and set the temperature to 4°C for pre-cooling. 3)将96深孔板从金属浴上拿下，用排枪吸取50μL的PM1加入到样本孔中，盖上胶套，1600rpm振荡1min，放在37℃金属浴孵育5min后280xg离心1min。3) Remove the 96-deep-well plate from the metal bath, add 50 μL of PM1 to the sample well with a discharge gun, cover with a rubber sleeve, shake at 1600 rpm for 1 min, and incubate in a 37°C metal bath for 5 min, then centrifuge at 280 xg for 1 min. 4)用排枪吸取155μL的异丙醇加入到样本孔中，盖上新胶套，上下翻转10次，置于4℃冰箱30min。4) Pipet 155 μL of isopropanol into the sample well with a discharge gun, cover with a new rubber sleeve, turn it up and down 10 times, and place it in a 4°C refrigerator for 30 minutes. 5)将96深孔板4℃，3000xg，离心20min后，敲干液体，悬空倒置在超净工作台，风干1h。5) Centrifuge the 96 deep-well plate at 4°C, 3000×g for 20 min, knock the liquid dry, place it upside down on the ultra-clean workbench, and air dry for 1 h. (5)重悬MSA3(5) Resuspend MSA3 1)将RA1提前取出融化。1) Take out RA1 in advance and melt it. 2)将杂交炉温度调至48℃，提前打开封铝膜仪器，提前将金属浴调至95℃。2) Adjust the temperature of the hybridization furnace to 48°C, open the aluminum sealing device in advance, and adjust the metal bath to 95°C in advance. 3)用排枪吸取23μL的RA1加入到样本孔中，封上铝膜，置于48℃的杂交炉中孵育1h，孵育完成后1800rpm，振荡1min，短暂离心(≤280xg)后置于95℃金属浴孵育20min，室温放置30min，短暂离心(≤280xg)。3) Pipette 23 μL of RA1 into the sample well with a discharge gun, seal with aluminum film, and incubate in a hybridization oven at 48°C for 1 hour. After incubation, 1800rpm, shake for 1min, briefly centrifuge (≤280xg), and place it on a metal plate at 95°C. Incubate in the bath for 20 min, place at room temperature for 30 min, and centrifuge briefly (≤280×g). (6)芯片杂交(6) Chip hybridization 1)在芯片盒上下孔槽中各加入450μL PB2。1) Add 450 μL of PB2 to the upper and lower wells of the chip box. 2)将芯片安装至芯片盒，条码端靠近自己，吸取15μL样本至记录单对应的芯片孔。2) Install the chip into the chip box, with the barcode end close to you, and draw 15 μL of sample to the chip hole corresponding to the record sheet. 3)小心盖上芯片盒，平稳放入杂交炉，打开摇振模式，48℃孵育16-20h。3) Carefully cover the chip box, put it into the hybridization oven smoothly, turn on the shaking mode, and incubate at 48°C for 16-20h. (7)清洗芯片(7) Cleaning the chip 1)将芯片盒从杂交炉中取出，放置在室温冷却25min。1) Take the chip cassette out of the hybridization oven and place it at room temperature to cool for 25 minutes. 2)两个玻璃皿中各加入200μL PB1，取出芯片，小心去掉封膜，第一个玻璃皿上下提拉1min后放入第二个玻璃皿上下提拉1min。2) Add 200 μL of PB1 to each of the two glass dishes, take out the chip, carefully remove the sealing film, lift the first glass dish up and down for 1 min, and then put it into the second glass dish and pull it up and down for 1 min. (8)芯片染色(8) Chip staining 1)提前打开空气浴，仪器设置45.75℃左右，以温度计测量仪器表面温度为44℃为准(由于热损耗，设置温度稍大于实际温度)。1) Turn on the air bath in advance, and set the instrument to about 45.75°C, based on the surface temperature of the thermometer measuring 44°C (due to heat loss, the set temperature is slightly higher than the actual temperature). 2)提前一天在XC4试剂瓶中加入330mL无水乙醇，用力摇匀15s后室温静置，使用前再次用力摇匀后静置。2) Add 330 mL of absolute ethanol to the XC4 reagent bottle one day in advance, shake vigorously for 15s, and then let it stand at room temperature. Shake it again before use and let it stand. 3)以甲酰胺：去离子水：0.5M EDTA按47.5:2.4:0.1的比例配制95％甲酰胺。3) Prepare 95% formamide with formamide: deionized water: 0.5M EDTA in a ratio of 47.5:2.4:0.1. 4)将RA1、XC1、XC2、TEM、STM、ATM置于常温融化，取出XC3、PB1常温试剂。4) Melt RA1, XC1, XC2, TEM, STM, ATM at room temperature, and take out XC3, PB1 room temperature reagents. 5)芯片固定盒中加入150mL PB1，以支架+芯片+隔膜+玻片+铁架片顺序组成芯片组合体，条码端靠近自己，剪去隔膜无条码端，条码端朝上，置于44℃空气浴。5) Add 150 mL of PB1 to the chip fixing box, form a chip assembly in the order of bracket + chip + diaphragm + glass slide + iron frame sheet, the barcode end is close to you, cut off the non-barcode end of the diaphragm, and place the barcode end up at 44°C Air bath. 6)芯片与玻片之间形成孔槽，向孔槽中每隔30s加入150μL RA1，重复6次。6) A hole is formed between the chip and the glass slide, and 150 μL of RA1 is added to the hole every 30s, repeating 6 times. 7)加入450μL XC1，孵育10min。7) Add 450 μL of XC1 and incubate for 10 min. 8)加入450μL XC2，孵育10min。8) Add 450 μL XC2 and incubate for 10 min. 9)加入200μL TEM，孵育15min。9) Add 200 μL of TEM and incubate for 15 min. 10)加入450μL 95％甲酰胺，孵育1min后再次加入450μL 95％甲酰胺，孵育6min。10) Add 450 μL of 95% formamide, incubate for 1 min, add 450 μL of 95% formamide again, and incubate for 6 min. 11)将空气浴温度调至表面实际温度为STM试剂管标注温度。11) Adjust the temperature of the air bath to the actual temperature of the surface, which is the marked temperature of the STM reagent tube. 12)加入450μL XC3，孵育1min后再次加入450μL XC3，孵育20min。12) Add 450 μL XC3, incubate for 1 min, add 450 μL XC3 again, and incubate for 20 min. 13)调节空气浴至32.0℃左右。13) Adjust the air bath to about 32.0°C. 14)待空气浴温度降至STM试剂管标注温度，加入250μL STM，孵育10min。14) When the temperature of the air bath drops to the temperature marked on the STM reagent tube, add 250 μL of STM and incubate for 10 min. 15)加入450μL XC3，孵育1min后再次加入450μL XC3，孵育5min。15) Add 450 μL XC3, incubate for 1 min, add 450 μL XC3 again, and incubate for 5 min. 16)加入250μL ATM，孵育10min。16) Add 250 μL of ATM and incubate for 10 min. 17)加入450μL XC3，孵育1min后再次加入450μL XC3，孵育5min。17) Add 450 μL XC3, incubate for 1 min, add 450 μL XC3 again, and incubate for 5 min. 18)加入250μL STM，孵育10min。18) Add 250 μL of STM and incubate for 10 min. 19)加入450μL XC3，孵育1min后再次加入450μL XC3，孵育5min。19) Add 450 μL XC3, incubate for 1 min, add 450 μL XC3 again, and incubate for 5 min. 20)加入250μL ATM，孵育10min。20) Add 250 μL of ATM and incubate for 10 min. 21)加入450μL XC3，孵育1min后再次加入450μL XC3，孵育5min。21) Add 450 μL XC3, incubate for 1 min, add 450 μL XC3 again, and incubate for 5 min. 22)加入250μL STM，孵育10min。22) Add 250 μL of STM and incubate for 10 min. 23)加入450μL XC3，孵育1min后再次加入450μL XC3，孵育5min。23) Add 450 μL XC3, incubate for 1 min, add 450 μL XC3 again, and incubate for 5 min. 24)塑料皿提前加入310mL PB1，取下所有芯片，关闭空气浴，用锉刀拆除铁夹片，回收铁夹片、玻片和支架，丢弃隔膜，将芯片置于塑料皿中的架子上，条码端朝上，上下提拉十次，静置5min。24) Add 310mL PB1 to the plastic dish in advance, remove all chips, turn off the air bath, remove the iron clips with a file, recover the iron clips, glass slides and holders, discard the septum, place the chips on the rack in the plastic dish, barcode With the end facing up, pull up and down ten times, and let it stand for 5 minutes. 25)另一只塑料皿中提前加入310mL XC4，将放置芯片的架子放入塑料皿中，上下提拉十次，静置5min。25) Add 310 mL of XC4 to another plastic dish in advance, put the rack on which the chip is placed into the plastic dish, pull it up and down ten times, and let it stand for 5 minutes. 26)用镊子夹住芯片条码端，依次夹出芯片，小心的在塑料皿边缘沥出多余的液体后水平放置在芯片架上，小心放入到吸真空器中，抽50-55min左右，直至芯片表面XC4被抽干，取出芯片。26) Use tweezers to clamp the barcode end of the chip, and take out the chips in turn. Carefully drain the excess liquid from the edge of the plastic dish and place it horizontally on the chip holder. Carefully put it into a vacuum cleaner for about 50-55 minutes, until The chip surface XC4 was drained, and the chip was taken out. (9)基因芯片扫描(9) Gene chip scanning 1)根据芯片ID号提前在Illumina提供的Decode File Client Support软件上下载每张芯片对应的DAMP文件，放入到iScan扫描仪连接的电脑对应路径中。1) Download the DAMP file corresponding to each chip on the Decode File Client Support software provided by Illumina in advance according to the chip ID number, and put it into the corresponding path of the computer connected to the iScan scanner. 2)打开iScan扫描仪和电脑上的iScan Control Software系统，等仪器自动初始化后点击“Start”自动打开机舱，将芯片放置在机舱金属台上的芯片槽上，按压金属台两边的按钮调整芯片位置直至完整卡入槽内，点击“Next”，等待扫描仪扫描芯片条码，扫描完成后选择Input Path为放置芯片DAMP文件的文件夹，选择Output Path为数据输出的文件夹，点击“Scan”进行扫描。2) Open the iScan scanner and the iScan Control Software system on the computer. After the instrument is automatically initialized, click 'Start' to automatically open the cabin, place the chip on the chip slot on the metal table of the cabin, and press the buttons on both sides of the metal table to adjust the position of the chip. Click 'Next' until it is fully inserted into the slot, and wait for the scanner to scan the barcode of the chip. After scanning, select Input Path as the folder for placing the chip DAMP file, select Output Path as the folder for data output, and click 'Scan' to scan . 3)扫描完成后，点击“Done”，按扫描仪上按钮打开机舱，按住金属台两旁按钮取出芯片，放入到原本放置芯片的包装盒中，常温保存，按扫描仪上按钮关闭。3) After scanning, click 'Done', press the button on the scanner to open the cabin, press the buttons on both sides of the metal table to take out the chip, put it in the original packaging box where the chip was placed, save it at room temperature, and press the button on the scanner to close. 4)在数据输出的文件夹中拷贝出每张芯片的IDAT文件，关闭iScan ControlSoftware系统和iScan扫描仪。4) Copy the IDAT file of each chip in the data output folder, and close the iScan ControlSoftware system and the iScan scanner. (10)基因芯片数据质控(10) Gene chip data quality control 通过对原始基因芯片数据进行软件分析，Genome Studio会提供call rate(检出率)值，代表检测出来的SNP位点占总SNP位点数的比例，数值越高，数据质量越好，其值最高是100％；Karyo Studio可以提供LogR dev值，是CNV均一性的波动指标，数值越高，均一性越差，CNV分析越困难。Through software analysis of the original gene chip data, Genome Studio will provide a call rate (call rate) value, which represents the ratio of the detected SNP sites to the total number of SNP sites. The higher the value, the better the data quality, and the highest value. is 100%; Karyo Studio can provide the LogR dev value, which is a fluctuation indicator of CNV uniformity. The higher the value, the worse the uniformity and the more difficult the CNV analysis. (11)基因芯片分析原理与流程(11) Principle and process of gene chip analysis CNV主要通过log R ratio(LRR)和B allele frequency(BAF)这两个指标进行计算，LRR为观察到的荧光强度与预期荧光强度之间的比值，BAF为Infinium指定B等位基因的比例，在正常样本中，AA、BB和AB的BAF值分别趋向于0、1和0.5，如果一个位点的BAF值接近0.66，则表明出现重复(ABB)。CNV is mainly calculated by two indicators: log R ratio (LRR) and Ballele frequency (BAF). LRR is the ratio between the observed fluorescence intensity and the expected fluorescence intensity, and BAF is the ratio of the B allele specified by Infinium. In normal samples, the BAF values of AA, BB, and AB tended to be 0, 1, and 0.5, respectively, and if a locus had a BAF value close to 0.66, it indicated a duplication (ABB). 通过比较观察到LRR和BAF值，计算每个位点的初步拷贝数评估值。L0为纯合缺失的可能性，L1为单倍体的可能性，L2为二倍体的可能性，L3为三倍体的可能性，L4为四倍体的可能性，计算公式如下：Preliminary copy number estimates for each locus were calculated by comparing observed LRR and BAF values. L 0 is the likelihood of a homozygous deletion, L 1 is the likelihood of a haploid, L 2 is the likelihood of a diploid, L 3 is the likelihood of a triploid, L 4 is the likelihood of a tetraploid, Calculated as follows: L0＝LDDL 0 =L DD L1＝LA+LBL 1 =L A +L B L2＝LAA+LAB+LBBL 2 =L AA +L AB +L BB L3＝LAAA+LAAB+LABB+LBBBL 3 =L AAA +L AAB +L ABB +L BBB L4＝LAAAA+LAAAB+LABBB+LBBBBL 4 =L AAAA +L AAAB +L ABBB +L BBBB 其中，计算给定基因型AAB的可能性LAAB，可以使用表1的参数和以下标准值：Among them, to calculate the likelihood of a given genotype AAB, L AAB , the parameters of Table 1 and the following standard values can be used: CNV计算14个基因型参数，基因型AABB没有建模，因为这代表两个独立的重复事件，在自然界很少发生。(CN＝拷贝数，DD＝纯合缺失，SD＝标准差)。CNV calculates 14 genotype parameters, and genotype AABB is not modeled because this represents two independent repetitive events that rarely occur in nature. (CN=copy number, DD=homozygous deletion, SD=standard deviation). 首先计算初步拷贝数估计值(X)，X为5个拷贝模型的平均值，由各自的可能性加权计算:A preliminary copy number estimate (X) is first calculated, where X is the average of the 5-copy models, weighted by their respective likelihoods: 随后使用滑动窗口的方法寻找最大|Zij|值，使用下列公式寻找最大值，在这里n为染色体上的位点数目。Then use the sliding window method to find the maximum |Z ij | value, using the following formula to find the maximum value, where n is the number of loci on the chromosome. Si＝X1+...+Xi,1≤i≤nS i =X 1 +...+X i , 1≤i≤n 接下来为每个连续断点之间的区域分配一个拷贝数，计算该区域内每个位点的L0，L1，L2，L3，L4。对于每一个假定的拷贝数K(0-4)，每个K的LK值对数相加，总和最高的K为该区域的拷贝数，对于拷贝数不是2的区域，会分配一个置信分值进行评估。Next, assign a copy number to the region between each consecutive breakpoint and calculate L 0 , L 1 , L 2 , L 3 , L 4 for each site within the region. For each assumed copy number K (0-4), the logarithm of the L K value for each K is added, and the K with the highest sum is the copy number of the region. For regions with a copy number other than 2, a confidence score is assigned. value is evaluated. 具体分析过程中使用分析软件(Karyo Studio或Genome Studio)，对同一家系样本进行原始基因芯片数据处理(.idat格式)，获得CNV结果展示界面。详细操作流程可参考软件运行操作说明书。In the specific analysis process, the analysis software (Karyo Studio or Genome Studio) was used to process the original gene chip data (.idat format) for samples from the same family to obtain the CNV result display interface. For detailed operation procedures, please refer to the software operation manual. 1-3号家系的CNV结果请见表1。图2展示了1号家系患者的CNV微缺失检测结果。The CNV results of families 1-3 are shown in Table 1. Figure 2 shows the results of CNV microdeletion detection for patients in family No. 1. 表1. 1-3号家系中患者CNV检测结果表Table 1. CNV test results of patients in families 1-3 家系编号family number 染色体数目number of chromosomes 患者patient 患者中检测到的CNVCNVs detected in patients CNV微缺失微重复综合征CNV microdeletion microduplication syndrome 11 4646 XYXY 7q11.23*17q11.23*1 Williams综合征Williams syndrome 22 4646 XXxx 22q11.21*122q11.21*1 22q11微缺失综合征22q11 microdeletion syndrome 33 4646 XXxx 17p12p11.2*317p12p11.2*3 Potocki-Lupski微重复综合征Potocki-Lupski microduplication syndrome 实施例2：体外受精、囊胚活检和全基因组扩增(WGA)Example 2: In vitro fertilization, blastocyst biopsy and whole genome amplification (WGA) 1、体外受精1. In vitro fertilization 对募集的家庭进行体外受精(IVF)，体外受精方法遵循本领域常规方法进行；这些家庭的母本/父本年龄、表型，排卵结果、受精卵数量和最终用于活检的囊胚数量列于表2。通过上述体外受精，3个家系共获得16枚囊胚进行后续的活检和单体型分析研究。In vitro fertilization (IVF) was performed on the recruited families following routine methods in the field; the maternal/paternal age, phenotype, ovulation results, number of fertilized eggs and number of blastocysts ultimately used for biopsy were listed for these families in Table 2. Through the above in vitro fertilization, a total of 16 blastocysts were obtained from the three families for subsequent biopsy and haplotype analysis. 表2. 1-2号家系基本情况和体外受精情况Table 2. Basic information and in vitro fertilization of No. 1-2 families 2、囊胚活检及全基因组扩增2. Blastocyst biopsy and whole genome amplification 取上述处于囊胚阶段的胚胎，在胚胎发育的第5或6天从滋养外胚层中移出3至10个细胞。将活检细胞置于装有碱性变性缓冲液(KOH)的PCR管中进行细胞裂解。再通过多重置换扩增(MDA)方法进行全基因组扩增(WGA)。依照试剂盒说明书中所述方法，用phi 29DNA聚合酶进行等温DNA扩增(Repli-g单细胞全基因组扩增试剂盒，QIAGEN GmbH，Hilden，Germany)，具体操作流程如下：The blastocyst stage embryos described above were taken and 3 to 10 cells were removed from the trophectoderm on day 5 or 6 of embryonic development. Biopsy cells were lysed in PCR tubes containing alkaline denaturing buffer (KOH). Whole genome amplification (WGA) was then performed by the multiple displacement amplification (MDA) method. According to the method described in the kit instructions, isothermal DNA amplification was performed with phi 29 DNA polymerase (Repli-g Single-Cell Whole Genome Amplification Kit, QIAGEN GmbH, Hilden, Germany). The specific operation process is as follows: (1)实验前准备(1) Preparation before the experiment 1)个人防护：根据实验室安全防护相关程序内容，更换实验服、戴帽子、口罩、鞋套进入实验室。1) Personal protection: According to the relevant procedures of laboratory safety protection, change lab coats, wear hats, masks, and shoe covers to enter the laboratory. 2)紫外消毒：打开超净工作台内的紫外灯，杀菌30min，关闭紫外灯，打开风机，通风10min。2) UV disinfection: turn on the UV lamp in the ultra-clean workbench, sterilize for 30 minutes, turn off the UV lamp, turn on the fan, and ventilate for 10 minutes. 3)打印相关材料：实验操作记录单、条码等。3) Printing related materials: experimental operation record sheet, barcode, etc. 4)仪器准备：检查设备是否正常，包括涡旋混合仪、掌上三管离心机，PCR仪等。4) Instrument preparation: Check whether the equipment is normal, including vortex mixer, palm three-tube centrifuge, PCR machine, etc. 5)试剂盒准备：准备单细胞全基因组扩增试剂(MDA法)，检查试剂盒中各组分是否齐全完好且在效期内，提前将试剂置于冰盒上备用。5) Kit preparation: prepare single-cell whole genome amplification reagent (MDA method), check whether all components in the kit are complete and within the validity period, and put the reagent on ice box in advance for use. 6)耗材准备：包括各种规格滤芯吸头，0.2mL进口EP管，1.5mL进口EP管，双面板，冰盒。6) Preparation of consumables: including various specifications of filter tips, 0.2mL imported EP tubes, 1.5mL imported EP tubes, double-sided panels, and ice boxes. 7)样本准备：核实样本姓名与编号是否一致，核实一致后将样本置于冰盒上备用。7) Sample preparation: Verify that the name and number of the sample are consistent, and place the sample on the ice box for later use after verifying the consistency. 8)阳性对照准备：准备一个阳性对照，阳性对照为含有5-10个细胞的2.5μL样本(确保管内一定有细胞)。8) Positive control preparation: prepare a positive control, which is a 2.5 μL sample containing 5-10 cells (make sure there are cells in the tube). (2)MDA法单细胞全基因组扩增(2) Single-cell whole-genome amplification by MDA method 1)准备两个0.2mL进口EP管，分别加入2.5μL和4μL水，作为体积对照管备用。1) Prepare two 0.2mL inlet EP tubes, add 2.5μL and 4μL water respectively, as volume control tubes for future use. 2)将样本离心1min，检查液体体积，与对照管进行比对，拍照保存将比对结果记录在册，做到样本体积可追溯。2) Centrifuge the sample for 1 min, check the liquid volume, compare it with the control tube, take a picture and save the comparison result and record the comparison result, so that the sample volume can be traced back. 3)准备Buffer D2(下表给出的Buffer D2体积足够12个反应，一次实验未完全用完可储存于-20℃，但储存时间不能超过3个月)。3) Prepare Buffer D2 (the volume of Buffer D2 given in the table below is enough for 12 reactions, and it can be stored at -20°C if one experiment is not completely used up, but the storage time cannot exceed 3 months). 组分component 体积volume DTT，1MDTT, 1M 3μL3μL Reconstituted Buffer DLBReconstituted Buffer DLB 33μL33μL 总体积total capacity 36μL36μL 4)在每个样本管中加入3μL Buffer D2，轻弹管壁混匀并短暂离心收集于管底，离心结束的样品管放入PCR冰盒中。注意：确保管内液体没有粘附在管壁上，勿使用移液器吹打，避免细胞样本粘附到移液器的吸头上。4) Add 3 μL of Buffer D2 to each sample tube, flick the tube wall to mix, and centrifuge briefly to collect at the bottom of the tube. The sample tube after centrifugation is placed in the PCR ice box. Note: Make sure that the liquid in the tube does not adhere to the tube wall, do not use a pipette to blow, to avoid the cell sample from sticking to the pipette tip. 5)打开PCR仪，设置PCR程序如下：65℃10min；4℃hold(热盖温度：105℃)。5) Turn on the PCR machine, and set the PCR program as follows: 65°C for 10 min; hold at 4°C (hot lid temperature: 105°C). 6)把样本管放置在PCR仪中进行裂解反应，PCR反应结束后，迅速加入3μL StopSolution，轻弹管壁混匀并短暂离心。下步反应混合液准备好之前将样本置于冰盒上。6) Place the sample tube in the PCR machine for lysis reaction. After the PCR reaction is over, quickly add 3 μL of StopSolution, flick the tube wall to mix and centrifuge briefly. Place samples on ice until the next reaction mixture is ready. 7)准备反应混合液：7) Prepare the reaction mixture: 组分component 体积volume H2O scH2O sc 9μL9μL REPLI-g sc Reaction BufferREPLI-g sc Reaction Buffer 29μL29μL REPLI-g sc DNA PolymeraseREPLI-g sc DNA Polymerase 2μL2μL 总体积total capacity 40μL40μL 8)立即将40μL反应混合液加入到准备好的10μL DNA样本中(第4.2.7步)，充分振荡混匀并短暂离心收集。8) Immediately add 40 μL of the reaction mixture to the prepared 10 μL DNA sample (step 4.2.7), mix well and centrifuge briefly to collect. 9)把上述样本放入到PCR仪内，进行单细胞扩增反应，PCR程序如下：30℃59min59s8cycles；65℃3min；4℃Hold。9) Put the above sample into the PCR machine, and perform single-cell amplification reaction. The PCR program is as follows: 30°C for 59min59s8cycles; 65°C for 3min; 4°C Hold. 10)将扩增产物-20℃保存备用。10) Store the amplified product at -20°C for later use. (3)扩增产物浓度测定(3) Determination of Amplification Product Concentration 1)用Qubit定量：MDA扩增产物无核酸酶水稀释10倍后进行浓度测定。1) Quantification with Qubit: The MDA amplification product was diluted 10 times with nuclease-free water for concentration determination. 2)浓度质检合格要求：所有样本测定后浓度≥300ng/μL。若浓度低于此范围，则不进行后续实验，并分析原因。2) Concentration quality inspection qualification requirements: the concentration of all samples after determination is ≥300ng/μL. If the concentration is lower than this range, no follow-up experiments will be performed, and the reasons will be analyzed. (4)MDA扩增产物质检(4) MDA amplification product quality inspection 1)实验前准备1) Preparation before experiment a)个人防护：根据实验室安全防护相关程序内容，更换实验服、戴帽子、口罩、鞋套进入实验室。a) Personal protection: According to the relevant procedures of laboratory safety protection, change the laboratory coat, wear a hat, mask, and shoe cover to enter the laboratory. b)紫外消毒：打开超净工作台内的紫外灯，杀菌30min，关闭紫外灯，打开风机，3级风，通风10min。b) Ultraviolet disinfection: turn on the ultraviolet lamp in the ultra-clean workbench, sterilize for 30 minutes, turn off the ultraviolet lamp, turn on the fan, and ventilate for 10 minutes. c)打印相关材料：实验操作记录单、条码等。c) Printing related materials: experimental operation record sheet, barcode, etc. d)仪器准备：检查设备是否正常，包括掌上三管离心机，微量台式离心机，qPCR仪等。d) Instrument preparation: Check whether the equipment is normal, including palm three-tube centrifuge, micro-tabletop centrifuge, qPCR instrument, etc. e)试剂准备：包括qPCR试剂，无核酸酶水，检查试剂盒中各组分是否齐全完好且在效期内，并放置冰盒上溶解备用。e) Reagent preparation: including qPCR reagents, nuclease-free water, check whether the components in the kit are complete and within the validity period, and place them on an ice box to dissolve for later use. f)耗材准备：包括各种规格滤芯吸头，1.5mL进口EP管，2mL进口EP管，QPCR专用八连管及管盖，双面板，冰盒。f) Preparation of consumables: including filter tips of various specifications, 1.5mL imported EP tubes, 2mL imported EP tubes, eight-connected tubes and caps for QPCR, double-sided panels, and ice box. g)样本准备：核实样本姓名与编号是否一致，核实一致后将样本放置冰盒上备用。g) Sample preparation: Verify whether the name and number of the sample are consistent, and place the sample on the ice box for later use after verifying the consistency. 2)引物准备2) Primer preparation 质检引物设计时，考虑到单细胞扩增产物完整性及不同扩增子扩增效率存在差异，尽量满足扩增产物分布在不同的染色体上，且扩增产物长度有不同。When designing quality inspection primers, considering the integrity of single-cell amplification products and the differences in the amplification efficiency of different amplicon, try to satisfy that the amplification products are distributed on different chromosomes, and the lengths of the amplification products are different. 具体引物对应扩增产物DNA序列如下：The specific primers correspond to the DNA sequences of the amplified products as follows: MQ1：MQ1: GCCTGCCCAGACCTAGTAATTGCTGTAGTCTTTTCCTTTTGGATTCCTAGCAGTGGATGCTTGAATACAAATACCAAGTGGGCTCCAGCCAGTGAGGGTAATAGTGTACAGCAGTAAACTGTCTGTTAGCTGATGCTTACATTTCAGACAAATTGAGGAGGTTGTCAAAGGCATTAGCTTCTATCCTTTCCAGGGAATCAATCTGAGAGATTTCACTAGGGAAGAGAGGAGGGGGAAAAAGAGAAAGAAACATGAAAGAAATGACCGTGTCTGCATGATTATGAGCTATGTGTGTGACCCAACAACTGGGGACACCACTGTGTCCCCCTGAAAAGAACAAAGATGTGCAAGTTGTCCCCAAATCATACAGTGCTAACATCTCCCTTTAGGAGCACTGATGGGCAGCCTGCCCAGACCTAGTAATTGCTGTAGTCTTTTCCTTTTGGATTCCTAGCAGTGGATGCTTGAATACAAATACCAAGTGGGCTCCAGCCAGTGAGGGTAATAGTGTACAGCAGTAAACTGTCTGTTAGCTGATGCTTACATTTCAGACAAATTGAGGAGGTTGTCAAAGGCATTAGCTTCTATCCTTTCCAGGGAATCAATCTGAGAGATTTCACTAGGGAAGAGAGGAGGGGGAAAAAGAGAAAGAAACATGAAAGAAATGACCGTGTCTGCATGATTATGAGCTATGTGTGTGACCCAACAACTGGGGACACCACTGTGTCCCCCTGAAAAGAACAAAGATGTGCAAGTTGTCCCCAAATCATACAGTGCTAACATCTCCCTTTAGGAGCACTGATGGGCA MQ2：MQ2: TTTCGACATGGAGGCCACTGGCTTGCCCTTCTCCCAGCCCAAGGTCACGGAGCTGTGCCTGCTGGCTGTCCACAGATGTGCCCTGGAGAGCCCCCCCACCTCTCAGGGGCCACCTCCCACAGTTCCTCCACCACCGCGTGTGGTAGACAAGCTCTCCCTGTGTGTGGCTCCGGGGAAGGCCTGCAGCCCTGCAGCCAGCGAGATCACAGGTCTGAGCACAGCTGTGCTGGCAGCGCATGGGCGTCAATGTTTTGATGACAACCTGGCCAACCTGCTCCTAGCCTTCCTGCGGCGCCAGCCACAGCCCTGGTGCCTGGTGGCACACAATGGTGACCGCTACGACTTCCCCCTGCTCCAAGCAGAGCTGGCTATGCTGGGCCTCACCAGTGCTCTGGATGGTGCCTTCTGTGTGGATAGCATCACTGCGCTGAAGGCCCTGGAGCGAGCAAGCAGCCCCTCAGAACACGGCCCAAGGAAGAGCTATAGCCTAGGCAGCATCTACACTCGCCTGTATGGGCAGTCCCCTCCAGACTCGCACACGGCTGAGGGTGATGTCCTGGCCCTGCTCAGCATCTGTCAGTGGAGACCACAGGCCCTGCTGCGGTGGGTGGATGCTCACGCCAGGCCTTTCGGCACCATCAGGCCCATGTATGGGGTCACAGCCTCTGCTAGGACCAAGCCAAGACCATCTGCTGTCACAACCACTGCACACCTGGCCACAACCAGGAACACTAGTCCCAGCCTTTTCGACATGGAGGCCACTGGCTTGCCCTTCTCCCAGCCCAAGGTCACGGAGCTGTGCCTGCTGGCTGTCCACAGATGTGCCCTGGAGAGCCCCCCCACCTCTCAGGGGCCACCTCCCACAGTTCCTCCACCACCGCGTGTGGTAGACAAGCTCTCCCTGTGTGTGGCTCCGGGGAAGGCCTGCAGCCCTGCAGCCAGCGAGATCACAGGTCTGAGCACAGCTGTGCTGGCAGCGCATGGGCGTCAATGTTTTGATGACAACCTGGCCAACCTGCTCCTAGCCTTCCTGCGGCGCCAGCCACAGCCCTGGTGCCTGGTGGCACACAATGGTGACCGCTACGACTTCCCCCTGCTCCAAGCAGAGCTGGCTATGCTGGGCCTCACCAGTGCTCTGGATGGTGCCTTCTGTGTGGATAGCATCACTGCGCTGAAGGCCCTGGAGCGAGCAAGCAGCCCCTCAGAACACGGCCCAAGGAAGAGCTATAGCCTAGGCAGCATCTACACTCGCCTGTATGGGCAGTCCCCTCCAGACTCGCACACGGCTGAGGGTGATGTCCTGGCCCTGCTCAGCATCTGTCAGTGGAGACCACAGGCCCTGCTGCGGTGGGTGGATGCTCACGCCAGGCCTTTCGGCACCATCAGGCCCATGTATGGGGTCACAGCCTCTGCTAGGACCAAGCCAAGACCATCTGCTGTCACAACCACTGCACACCTGGCCACAACCAGGAACACTAGTCCCAGCCT MQ3：MQ3: GGGTTGTCCCCTGGATATAGGAGGGGTGAGGTGGGTCAGAGGGTGCCGGGAGGGGCCTGGATCAGCACTTCAAAAGGTGGGTGCCCGCCACCCAGGGGTGGCCCCAAGGAGAGGAGAGGAGCTGGCCATGTGCAGAGATGGGGCCCTGTGATGCAGACACACCTCGGTACCAGTTGCGCAGGGAGGTCATGACGAAGAAGCGGATGGCCTGGTTCGAGCCCTGCTTCAGGACAGTGGCTGTGAGGCCCTGGTACGTCCCCTTCAGCCCTGCGGGAAGGCAGGCACGGGGTTACCCTGCAGCCTCTCAGGCCCCGGTTGGGAATTGGTGTGTGTGGGGGGTGGGTGTTGCACAAAGCCCAAGGCAGGATGGGAGGTGCAGGCCCTTCCCACCCTGGCCCAGGTCCCTGAGCCCTATCAGGAAGGTCGAGTGGCTCACCTTGTTCCCGCACAATCTCCCTAACCCCGTGGAAGAATCCTCTGTACTTGGGGTTTGGGGAGGTCTGGTCGTGGATGAACTTGGGTTGTCCCCTGGATATAGGAGGGGTGAGGTGGGTCAGAGGGTGCCGGGAGGGGCCTGGATCAGCACTTCAAAAGGTGGGTGCCCGCCACCCAGGGGTGGCCCCAAGGAGAGGAGAGGAGCTGGCCATGTGCAGAGATGGGGCCCTGTGATGCAGACACACCTCGGTACCAGTTGCGCAGGGAGGTCATGACGAAGAAGCGGATGGCCTGGTTCGAGCCCTGCTTCAGGACAGTGGCTGTGAGGCCCTGGTACGTCCCCTTCAGCCCTGCGGGAAGGCAGGCACGGGGTTACCCTGCAGCCTCTCAGGCCCCGGTTGGGAATTGGTGTGTGTGGGGGGTGGGTGTTGCACAAAGCCCAAGGCAGGATGGGAGGTGCAGGCCCTTCCCACCCTGGCCCAGGTCCCTGAGCCCTATCAGGAAGGTCGAGTGGCTCACCTTGTTCCCGCACAATCTCCCTAACCCCGTGGAAGAATCCTCTGTACTTGGGGTTTGGGGAGGTCTGGTCGTGGATGAACTT MQ4：MQ4: TCAAGTTTCCTCTCACCTTTATTCTACTTCCTCATTAACAAGTCATCGGTTTGATACATTAATCATGGCAAAAAAATCACAGAGGAAGCACTAATCTGTCATTTTTTTCTGTGACCTGCAGACTCTTTGACACCCGGTACAGCATCCGGGAGAATGGGCAGCTCCTCACCATCCTGAGTGTGGAAGACAGTGATGATGGCTCAAGTTTCCTCTCACCTTTATTCTACTTCCTCATTAACAAGTCATCGGTTTGATACATTAATCATGGCAAAAAAATCACAGAGGAAGCACTAATCTGTCATTTTTTTCTGTGACCTGCAGACTCTTTGACACCCGGTACAGCATCCGGGAGAATGGGCAGCTCCTCACCATCCTGAGTGTGGAAGACAGTGATGATGGC MQ5：MQ5: GCGATCGATGCAGTGGACATGGTACTCATGGGAACAAGGTAGTTTACGAAGTTTGTTGCCTTCTGTATATTCTGTAATGCAAACACTACAGGTTTTTAATGCATCATTTTCACCAAAACTTCTCATTGCCAAGTTGTCAATCTGTTCTTTGGTGAGTCCTCTAGGTTGGTCATCATCATCCTCATTTAAGAGGAAAAACTGAGCCAGGCTAAGGAAGGGCAAAGAGCCACTTTCATCAAATGTGACTGGGGCCCTATGTCGACCCTCTCGCCTGGCACCTGATGAGCCTGATGATGAGCTTCCTTCATTACTGCCTTCAAATAAATCTGAGCTAGTTTCTGAACTTTCACCACCGGAACTGGAACTAGGACTGGAACTGGAACTTGAACTGGAACTGGAACTCGAACTGGAACTGGAACTCGAACTGGAACCAGAACTACTACCACCACCAGAACCTCCTCTTCCACTCCGTGACTCTGCCCTTTCCATATTTCGATTTGAGACTGAGCCAGTAGGCTCTGAGTCGCTATCACTGTACATAAAATAGCTTAACTCACCAAAACCTGTCATTATCTGCCTTAACATGGTCTGAATTGCAACAGATGTAGTCTCACTTAAACCAGTATTTAAGATTCTACGAATGGGAATTCTGATGGTACTGCGATCGATGCAGTGGACATGGTACTCATGGGAACAAGGTAGTTTACGAAGTTTGTTGCCTTCTGTATATTCTGTAATGCAAACACTACAGGTTTTTAATGCATCATTTTCACCAAAACTTCTCATTGCCAAGTTGTCAATCTGTTCTTTGGTGAGTCCTCTAGGTTGGTCATCATCATCCTCATTTAAGAGGAAAAACTGAGCCAGGCTAAGGAAGGGCAAAGAGCCACTTTCATCAAATGTGACTGGGGCCCTATGTCGACCCTCTCGCCTGGCACCTGATGAGCCTGATGATGAGCTTCCTTCATTACTGCCTTCAAATAAATCTGAGCTAGTTTCTGAACTTTCACCACCGGAACTGGAACTAGGACTGGAACTGGAACTTGAACTGGAACTGGAACTCGAACTGGAACTGGAACTCGAACTGGAACCAGAACTACTACCACCACCAGAACCTCCTCTTCCACTCCGTGACTCTGCCCTTTCCATATTTCGATTTGAGACTGAGCCAGTAGGCTCTGAGTCGCTATCACTGTACATAAAATAGCTTAACTCACCAAAACCTGTCATTATCTGCCTTAACATGGTCTGAATTGCAACAGATGTAGTCTCACTTAAACCAGTATTTAAGATTCTACGAATGGGAATTCTGATGGTACT MQ6：MQ6: CTCAAGACGTGGAGGCATCTGGGCTTAGCTGAGGTCACACTACTAGTGGGACCTACAGAAAAACCCAGGTGTGTCACCAGCAGGGCGGGCACCATCTCTGCAGCCGACACCAGCTTCCCCAACCTCCAGACAGGAGAAAGCATGAGGGTCCCCACTGAAATTCTGGCTCACAGAGTCACCTCCTATGCTGTGGCTTTTTTCAATCCCAGAGTTTGTCCAGCGAGGCAAAGACCTGGTCACGGCGTCTCTGGCTCACCAGGTGGAGGGAACGGCAAAACTCACGCTGGCCCAAGAGGAGGAACAGAGAAGCTTCCTGGCTGAGGCCCAGCCGACTGCTGACCCGGAAAAGTTTCTCGAGGTGACTCACATCCCCAGCCTCTGCACATGTGGGTGAGCCAGTTGTAGCTCTGTTCCCGTGACTGAGCACGGGACGCCGGAGGTATTCATCAGGCATGAGGTTATCTGCCTACTTCCCATGTGTCAGCTCAAGACGTGGAGGCATCTGGGCTTAGCTGAGGTCACACTACTAGTGGGACCTACAGAAAAACCCAGGTGTGTCACCAGCAGGGCGGGCACCATCTCTGCAGCCGACACCAGCTTCCCCAACCTCCAGACAGGAGAAAGCATGAGGGTCCCCACTGAAATTCTGGCTCACAGAGTCACCTCCTATGCTGTGGCTTTTTTCAATCCCAGAGTTTGTCCAGCGAGGCAAAGACCTGGTCACGGCGTCTCTGGCTCACCAGGTGGAGGGAACGGCAAAACTCACGCTGGCCCAAGAGGAGGAACAGAGAAGCTTCCTGGCTGAGGCCCAGCCGACTGCTGACCCGGAAAAGTTTCTCGAGGTGACTCACATCCCCAGCCTCTGCACATGTGGGTGAGCCAGTTGTAGCTCTGTTCCCGTGACTGAGCACGGGACGCCGGAGGTATTCATCAGGCATGAGGTTATCTGCCTACTTCCCATGTGTCAG a)将8对引物干粉12,000rpm离心1min，加无核酸酶水稀释至100μM母液，-20℃长期保存；使用时取少量母液稀释至2μM的工作液，-20℃保存备用。a) Centrifuge the dry powder of 8 pairs of primers at 12,000 rpm for 1 min, add nuclease-free water to dilute to 100 μM stock solution, and store at -20°C for a long time; when using, take a small amount of stock solution diluted to 2 μM working solution, and store at -20°C for later use. b)引物选择：一般情况下使用全部8对或部分引物进行MDA扩增产物进行质检验证，验证覆盖全面、可信度高。b) Primer selection: Generally, all 8 pairs or part of primers are used for quality inspection and verification of MDA amplification products, and the verification covers comprehensive and high reliability. 3)模板准备3) Template preparation a)MDA扩增产物：将定量后符合要求的MDA扩增产物用无核酸酶水稀释10倍，作为QPCR反应模板。a) MDA amplification product: The MDA amplification product that meets the requirements after quantification is diluted 10 times with nuclease-free water as a QPCR reaction template. b)阳性质控：混合的人外周血或人细胞系基因组DNA，浓度≈50ng/μL。b) Positive quality control: mixed human peripheral blood or human cell line genomic DNA, concentration ≈ 50ng/μL. c)阴性质控：无核酸酶水。c) Negative quality control: nuclease-free water. 4)配置PCR反应体系4) Configure PCR reaction system 下表为qPCR反应体系。The following table shows the qPCR reaction system. 试剂名称Reagent name 单管体系(20ul)Single tube system (20ul) 备注Remark KAPA SYBR Mix 2×KAPA SYBR Mix 2× 10μL10μL 含SYBR荧光染料的MixMix with SYBR Fluorescent Dye 模板DNAtemplate DNA 2μL2μL 注：MDA产物需稀释10倍Note: MDA product needs to be diluted 10 times 引物F，2μMPrimer F, 2 μM 3μL3μL 引物R，2μMPrimer R, 2 μM 3μL3μL High RoxHigh Rox 0.4μL0.4μL 注：根据不同仪器选用Note: Choose according to different instruments ddH2OddH2O 1.6μL1.6μL 5)PCR循环参数如下表所示5) PCR cycle parameters are shown in the table below 6)结果分析6) Result analysis I)判断标注：I) Judgment label: a.阳性结果：扩增产物熔解峰单一尖锐，Tm值预期范围固定；扩增曲线成典型S型，且一般Ct值≤28(不能>30)。a. Positive results: The melting peak of the amplification product is single and sharp, and the expected range of Tm value is fixed; the amplification curve is a typical S shape, and the general Ct value is ≤28 (can not be >30). 即同时满足4个条件(熔解峰单一尖锐、Tm值范围固定、S型曲线、Ct值≤28)则为阳性；若其中有条件不满足(尤其Ct值和熔解峰型)，则为阴性或弱阳性。That is, if four conditions are met at the same time (single sharp melting peak, fixed Tm value range, S-shaped curve, Ct value ≤ 28), it is positive; if one of the conditions is not satisfied (especially Ct value and melting peak type), it is negative or Weakly positive. b.阴性结果：扩增产物熔解峰多个，或无单一尖锐主峰，Tm值不在预期范围；扩增曲线不成典型S型，一般Ct值>30。b. Negative results: the amplification product has multiple melting peaks, or there is no single sharp main peak, and the Tm value is not within the expected range; the amplification curve is not typical S-shaped, and the general Ct value is >30. 即上述4个条件存在任何一个，则为阴性或弱阳性；尤其是Ct值>30必为阴性、熔解峰多个且无主峰必为阴性。That is, if any of the above 4 conditions exists, it is negative or weakly positive; in particular, the Ct value >30 must be negative, and it must be negative if there are multiple melting peaks and no main peak. II)结果分析流程：II) Result analysis process: a.按照“判定标准”原则，首先分析阳性质控和阴性质控，确保阳性质控结果为阳性，阴性质控结果为阴性。若阴阳性质控结果不正确，说明操作不当或试剂质量有问题，需排除原因重新验证。a. According to the principle of 'judgment standard', first analyze the positive quality control and negative quality control to ensure that the positive quality control result is positive and the negative quality control result is negative. If the negative and positive quality control results are incorrect, it indicates improper operation or a problem with the quality of the reagents, and it is necessary to eliminate the cause and re-verify. b.在阴阳性质控结果正确无误后分析MDA扩增产物，按照“判定标准”原则，对比阳性、阴性结果，逐一分析每个MDA扩增产物。b. Analyze the MDA amplification products after the negative and positive quality control results are correct. According to the 'judgment standard' principle, compare the positive and negative results, and analyze each MDA amplification product one by one. c.分析结果整理汇总，保留质检记录。c. The analysis results are sorted and summarized, and the quality inspection records are kept. 实施例3：SNP基因型分型和单体型(haplotypes)分析Example 3: SNP Genotyping and Haplotypes Analysis 1、SNP基因型检测1. SNP genotype detection 使用Illumina SNP微阵列进行SNP基因型检测。每个芯片包含近30万或70万个SNPs，可全面覆盖人23对染色体。将实施例2中进行囊胚活检和全基因组扩增获得的12个样本按照家系分组，分别与该家系患者夫妇、患者亲属的全基因组扩增样本3份编为一组，进行微阵列SNP基因型检测和分析，分组情况如表3所示。具体实验方法参照说明书进行，在此不再赘述。SNP genotyping was performed using Illumina SNP microarrays. Each chip contains nearly 300,000 or 700,000 SNPs, which can comprehensively cover 23 pairs of human chromosomes. The 12 samples obtained from blastocyst biopsy and whole-genome amplification in Example 2 were grouped according to family members, respectively grouped with 3 samples of whole-genome amplification samples from the family's patient couples and relatives of the patient, and microarray SNP gene analysis was performed. Type detection and analysis, the grouping situation is shown in Table 3. The specific experimental method is carried out with reference to the manual, and will not be repeated here. 表3. 1-2号家系SNP阵列实验分组Table 3. Groups of SNP array experiments in families No. 1-2 注：F代表女性，M代表男性Note: F is for female, M is for male 2、胚胎染色体非整倍体检测2. Detection of chromosomal aneuploidy in embryos SNP基因芯片检测胚胎染色体非整倍体的原理与流程如实施例1中(11)基因芯片分析原理与流程所述，此处不再重复描述。The principle and process of SNP gene chip detection of embryo chromosomal aneuploidy are as described in (11) Principle and process of gene chip analysis in Example 1, and the description will not be repeated here. 3、单体型分析3. Haplotype analysis 获得芯片检测的全部SNPs信息后，构建胚胎分子核型和家系单体型，分别用于鉴定胚胎是否携带致病性的CNV微缺失微重复综合征。具体操作方法如下：After obtaining all the SNPs information detected by the microarray, the embryo molecular karyotype and family haplotype were constructed to identify whether the embryo carried pathogenic CNV microdeletion and microduplication syndrome, respectively. The specific operation method is as follows: A.家系单体型构建：A. Family haplotype construction: 1)样本基因分型：将患者夫妇双方、患者亲属进行SNP基因分型；将患者夫妇双方和患者亲属称为参照样本；1) Sample genotyping: SNP genotyping is performed on both the patient's couple and the patient's relatives; the patient's couple and the patient's relatives are referred to as reference samples; 2)确定信息SNPs位点：信息SNPs的选择标准为：在CNV综合征患者中为杂合型，在其配偶中为纯合型，并且在患者亲属中也是纯合型的SNP位点；选择覆盖CNV断裂点、CNV所在染色体和与其相对应的正常的同源染色体上的信息SNPs，染色体每Mb范围内至少选择1个信息SNP；在覆盖CNV断裂点区域，信息SNPs从断裂点上下游1-5Mb范围内选择，优选自1-3Mb范围内选择；2) Determine informative SNPs loci: The selection criteria for informative SNPs are: SNP loci that are heterozygous in CNV syndrome patients, homozygous in their spouses, and homozygous in relatives of patients; select Covering the information SNPs on the CNV breakpoint, the chromosome where the CNV is located, and the corresponding normal homologous chromosomes, at least 1 information SNP is selected within each Mb range of the chromosome; in the area covering the CNV breakpoint, the information SNPs are 1 upstream and downstream from the breakpoint. Select from the range of -5Mb, preferably from the range of 1-3Mb; 3)构建家系单体型：集合步骤2)确定的信息SNPs位点通过家系连锁分析得到覆盖CNV两个断裂点区域、CNV所在整条染色体及其同源染色体的整条染色体的单体型，不同染色体单体型的集合称为家系单体型。3) Constructing the family haplotype: collecting the information SNPs determined in step 2) through family linkage analysis to obtain the haplotype covering the two breakpoint regions of the CNV, the entire chromosome where the CNV is located and the entire chromosome of its homologous chromosome, A collection of different chromosomal haplotypes is called a familial haplotype. B.鉴别CNV微缺失微重复综合征患病胚胎和正常胚胎的方法：B. Methods of Differentiating CNV Microdeletion Microduplication Syndrome Diseased Embryos from Normal Embryos: 将患者夫妇体外受精胚胎(囊胚)进行SNP基因分型，上述患者夫妇体外受精胚胎称为待定样本。将胚胎(囊胚)细胞中染色体单体型信息和参照样本的染色体单体型信息进行比对，着重关注家系单体型中CNV断裂点区域的单体型信息，通过整条染色体的单体型信息判断染色体易位断裂点区域是否发生了同源重组：SNP genotyping was performed on the in vitro fertilized embryos (blastocysts) of the patient couple, and the above in vitro fertilized embryos of the patient couple were referred to as pending samples. Compare the haplotype information of the embryo (blastocyst) cells with the haplotype information of the reference sample, focusing on the haplotype information of the CNV breakpoint region in the haplotype of the family, through the haplotype of the entire chromosome Type information to determine whether homologous recombination has occurred in the chromosomal translocation breakpoint region: i)当以与CNV微缺失微重复综合征患者具有相同疾病的亲属为参照时：i) When referring to relatives with the same disease as a patient with CNV microdeletion microduplication syndrome: a.若待定样本的染色体对应于家系单体型中CNV断裂点的区域没有发生重组，当待定样本该区域单体型信息和CNV综合征患者以及与患者具有相同疾病亲属的单体型信息一致时，则为CNV综合征患病胚胎；当待定样本该区域单体型信息和参照样本中CNV综合征患者一致，但与患者具有相同疾病亲属的单体型信息不一致时，则为不患CNV综合征的正常胚胎；a. If the chromosome of the undetermined sample does not recombine in the region corresponding to the CNV breakpoint in the family haplotype, when the haplotype information of the undetermined sample is consistent with the haplotype information of the CNV syndrome patient and relatives with the same disease as the patient When the haplotype information of the undetermined sample is consistent with the CNV syndrome patient in the reference sample, but inconsistent with the haplotype information of the patient with the same disease relatives, it is not suffering from CNV Syndromic normal embryos; b.若待定样本的染色体对应于家系单体型中CNV断裂点的区域发生了同源重组，则判断标准与i)a相反；b. If homologous recombination occurs in the chromosome of the undetermined sample corresponding to the CNV breakpoint in the family haplotype, the judgment standard is opposite to i)a; ii)当以CNV正常(不患CNV综合征)的亲属为参照时：ii) When referring to relatives with normal CNV (without CNV syndrome): a.若待定样本的染色体对应于家系单体型中CNV断裂点的区域没有发生重组，当待定样本该区域单体型信息和参照样本中CNV综合征患者以及与CNV正常不患CNV综合征的亲属的单体型信息一致时，则为不患CNV综合征的正常胚胎；当待定样本该区域单体型信息和参照样本中CNV综合征患者一致，但与CNV正常不患CNV综合征的亲属的单体型信息不一致时，则为CNV综合征患病胚胎；a. If there is no recombination in the region of the chromosome of the undetermined sample corresponding to the CNV breakpoint in the family haplotype, when the haplotype information in the region of the undetermined sample and the CNV syndrome patients in the reference sample and those with normal CNV without CNV syndrome When the haplotype information of the relatives is consistent, it is a normal embryo without CNV syndrome; when the haplotype information in the region of the pending sample is consistent with the CNV syndrome patient in the reference sample, but it is with normal CNV relatives without CNV syndrome When the haplotype information is inconsistent, it is a CNV syndrome diseased embryo; b.若待定样本的染色体对应于家系单体型中CNV断裂点的区域发生了同源重组，则判断标准与ii)a相反。b. If homologous recombination occurs in the chromosome of the undetermined sample corresponding to the CNV breakpoint in the family haplotype, the judgment standard is opposite to ii)a. 3、1-2号家系胚胎CNV预测结果3. CNV prediction results of embryos from families 1-2 图3展示了病例1家系参照样本和活检胚胎的CNV微缺失微重复综合征区域单体型分析结果。经过对CNV患者家系进行单体型连锁分析，对12个待移植胚胎进行诊断预测，2个是染色体非整倍体胚胎，10枚是整倍体胚胎；使用患者夫妇和患病亲属为参照，分析上述10例整倍体胚胎，结果显示：4枚是CNV正常的不患病胚胎(1号家系3枚，2号家系1枚)，其余的6枚是CNV患病的胚胎(1号家系5枚，2号家系1枚)，并且每个胚胎2个CNV断裂点区域的预测结果之间具有一致性。Figure 3 shows the results of haplotype analysis of the CNV microdeletion-microduplication syndrome region in reference samples and biopsy embryos from the family of Case 1. After haplotype linkage analysis of CNV patient families, 12 embryos to be transferred were diagnosed and predicted, 2 were chromosomal aneuploid embryos, and 10 were euploid embryos; using patient couples and affected relatives as reference, The above 10 euploid embryos were analyzed, and the results showed that: 4 were non-diseased embryos with normal CNV (3 in No. 1 family, 1 in No. 2 family), and the remaining 6 embryos were CNV diseased embryos (No. 1 family). 5, and 1 in family No. 2), and there was agreement between the predicted results of 2 CNV breakpoint regions per embryo. 表4.预测结果展示Table 4. Prediction result display 家系编号family number 活检胚胎数目number of embryos biopsied 不携带CNV胚胎数目Number of embryos not carrying CNV 携带CNV胚胎数目Number of CNV-carrying embryos 11 1010 33 55 22 22 11 11 33 44 00 44 实施例4：胚胎移植及胚胎CNV微缺失微重复筛查方法效果验证Example 4: Effect verification of embryo transfer and embryonic CNV microdeletion and microduplication screening method 1、胚胎移植1. Embryo transfer 按照本领域常规方法将上述实施例3表4中涉及的不患病胚胎用于胚胎移植。2个冷冻囊胚融化后均成活，一共经过了2个移植周期，家系1第一次移植后成功受孕，家系2在移植后成功着床，但通过后续随访该病例为生化妊娠。The non-diseased embryos mentioned in Table 4 of Example 3 above were used for embryo transfer according to conventional methods in the art. Both frozen blastocysts survived after being thawed. After a total of 2 transplantation cycles, family 1 was successfully conceived after the first transplant, and family 2 was successfully implanted after transplantation, but the case was a biochemical pregnancy after follow-up. 2、妊娠中期行羊水穿刺进行全基因组CNV检测分析验证2. Amniocentesis in mid-pregnancy for whole-genome CNV detection analysis and verification 胚胎移植成功后，通过与妊娠中期羊水细胞CNV检测来验证本发明所述鉴别CNV微缺失微重复综合征患病胚胎和正常胚胎方法的预测准确性。After successful embryo transfer, the prediction accuracy of the method for identifying CNV microdeletion microduplication syndrome diseased embryos and normal embryos according to the present invention is verified by CNV detection in amniotic fluid cells in the second trimester of pregnancy. (1)羊水细胞染色体制备方法(原位法)(1) Chromosome preparation method in amniotic fluid cells (in situ method) A.细胞培养A. Cell Culture 1).将羊水(约20ml)转移到无菌的离心管中，1000rpm离心10分钟；1). Transfer the amniotic fluid (about 20ml) to a sterile centrifuge tube and centrifuge at 1000rpm for 10 minutes; 2).去除上清液，用于其它分析，保留细胞悬液约0.5～1ml，用培养基混匀到2～2.5ml左右；2). Remove the supernatant for other analysis, keep about 0.5~1ml of cell suspension, and mix with medium to about 2~2.5ml; 3).将细胞悬液平分到2～4只Chromslide培养皿中；3). Divide the cell suspension into 2-4 Chromslide culture dishes; 4).培养24/48小时后，向每只Chromslide培养皿中加入约2.5ml羊水培养基；4). After culturing for 24/48 hours, add about 2.5ml of amniotic fluid medium to each Chromslide petri dish; 5).培养第5～6天后，对细胞生长状况进行观察，更换新的培养基；5). After the 5th to 6th day of culture, observe the growth of the cells and replace with a new medium; 6).1～2天后观察细胞的生长状况，如果细胞克隆数足够，向培养皿中加入秋水仙素，收获细胞，处理时间根据秋水溶液浓度确定。6). After 1 to 2 days, observe the growth of the cells. If the number of cell clones is sufficient, add colchicine to the culture dish to harvest the cells. The treatment time is determined according to the concentration of the autumn water solution. B.染色体制备B. Chromosome Preparation 1).倾斜Chromslide细胞培养皿，完全去除培养基；1). Tilt the Chromslide cell culture dish to completely remove the medium; 2).加入3～4ml低渗液到每个培养皿中，室温处理10分钟；2). Add 3-4ml of hypotonic solution to each petri dish and treat at room temperature for 10 minutes; 3).直接向低渗液中加入0.5～0.7ml固定液，室温处理5分钟；3). Add 0.5-0.7ml of fixative solution directly to the hypotonic solution, and treat at room temperature for 5 minutes; 4).去除上清液，加入3～4ml新鲜的固定液，室温处理；4). Remove the supernatant, add 3-4ml of fresh fixative, and treat at room temperature; 5).重复第四步1～2次；5). Repeat the fourth step 1 to 2 times; 6).去除固定液，在Maxchrome染色体分散仪(设定适当的参数)中进行染色体分散过程；6). Remove the fixative and carry out the chromosome dispersion process in the Maxchrome chromosome dispersion instrument (set appropriate parameters); 7).玻片干燥后，老化，显带。7). After drying, the slides are aged and banded. (2)羊水细胞CNV检测(2) CNV detection in amniotic fluid cells 使用IlluminaSNP微阵列基因芯片用于CNV检测，具体同实施例1。或使用高通量测序CNV-seq用于CNV检测，具体实验方法参照说明书进行，在此不再赘述。家系1病例移植后顺利妊娠，并已经到孕中期。家系2病例移植后成功着床，但通过后续随访该病例为生化妊娠，未能得到产前羊水细胞结果。表5显示了病例家系1已成功移植的胚胎使用本发明所述鉴别CNV微缺失微重复综合征患病胚胎和正常胚胎方法所获得的诊断预测结果与羊水穿刺进行CNV遗传学分析验证的结果的具体信息。Illumina SNP microarray gene chip was used for CNV detection, and the details were the same as in Example 1. Or use high-throughput sequencing CNV-seq for CNV detection, the specific experimental method is carried out according to the instructions, and will not be repeated here. Family 1 case successfully conceived after transplantation, and has reached the second trimester. The 2 cases in the family were successfully implanted after transplantation, but the case was a biochemical pregnancy after follow-up, and the results of prenatal amniotic fluid cells could not be obtained. Table 5 shows the results of diagnostic prediction obtained by the method of the present invention for identifying CNV microdeletion microduplication syndrome diseased embryos and normal embryos for embryos that have been successfully transferred in case family 1 and the results of CNV genetic analysis and verification by amniocentesis specific information. 表5.PGT检测胚胎结果与移植后胎儿羊水穿刺细胞遗传学验证结果比较Table 5. Comparison between the results of PGT detection of embryos and the results of fetal amniocentesis cytogenetic verification after transplantation 由表5可知，经过验证，家系单体型的预测结果和羊水穿刺术中细胞的遗传学分析结果完全一致，证明本发明所述的鉴别CNV微缺失微重复综合征患病胚胎和正常胚胎方法准确可靠。As can be seen from Table 5, after verification, the predicted results of family haplotypes are completely consistent with the results of genetic analysis of cells in amniocentesis, which proves that the method for identifying CNV microdeletion and microduplication syndrome diseased embryos and normal embryos according to the present invention is completely consistent. Accurate and reliable.

### Claims

Claims (9) Translated from Chinese 1.一种用于鉴别CNV微缺失微重复综合征患病胚胎和正常胚胎的家系单体型构建方法，其特征在于，包含以下步骤：1. a family haplotype construction method for identifying CNV microdeletion microduplication syndrome diseased embryos and normal embryos, is characterized in that, comprises the following steps: 1)样本基因分型：将CNV微缺失微重复综合征患者夫妇双方、和至少一名患者亲属进行大规模SNP基因型检测；将患者夫妇双方和患者亲属称为参照样本；优选地，所述患者亲属可选自患者的父母、子女、兄弟姐妹，或患有CNV微缺失微重复综合征的患者夫妇流产、引产或活产胎儿组织；所述患者亲属优先选择流产、引产或活产的患病胎儿，也可选择其他患者亲属；更优选地，所述患者亲属可选自同样患有CNV微缺失微重复综合征的亲属，也可选自染色体正常的亲属；1) Sample genotyping: perform large-scale SNP genotyping on both the couple and at least one relative of the patient with CNV microdeletion and microduplication syndrome; both the couple and the patient's relative are referred to as reference samples; preferably, the The patient's relatives can be selected from the patient's parents, children, siblings, or the patient's couple with CNV microdeletion microduplication syndrome who have abortion, induced labor or live birth fetal tissue; For the sick fetus, other relatives of the patient can also be selected; more preferably, the relatives of the patient can be selected from relatives who also suffer from CNV microdeletion and microduplication syndrome, and can also be selected from relatives with normal chromosomes; 2)确定信息SNPs位点：信息SNPs的选择标准为：在CNV微缺失微重复综合征患者中为杂合型，在其配偶中为纯合型，并且在患者亲属中也是纯合型的SNP位点；选择覆盖CNV断裂点、CNV所在染色体和与其相对应的正常的同源染色体上的信息SNPs，染色体每Mb范围内至少选择1个信息SNP；在覆盖CNV断裂点区域，信息SNPs从断裂点上下游1-5Mb范围内选择，优选自1-3Mb范围内选择；2) Identify informative SNPs loci: The selection criteria for informative SNPs are: SNPs that are heterozygous in CNV microdeletion-microduplication syndrome patients, homozygous in their spouses, and homozygous in relatives of patients Site; select the informative SNPs covering the CNV breakpoint, the chromosome where the CNV is located, and its corresponding normal homologous chromosome, and at least one informative SNP is selected within each Mb range of the chromosome; in the area covering the CNV breakpoint, the informative SNPs are derived from the Select from the range of 1-5Mb upstream and downstream, preferably from the range of 1-3Mb; 3)构建家系单体型：集合步骤2)确定的信息SNPs位点通过家系连锁分析得到覆盖CNV两个断裂点区域、CNV所在整条染色体及其同源染色体的整条染色体的单体型，不同染色体单体型的集合称为家系单体型。3) Constructing the family haplotype: collecting the information SNPs determined in step 2) through family linkage analysis to obtain the haplotype covering the two breakpoint regions of the CNV, the entire chromosome where the CNV is located and the entire chromosome of its homologous chromosome, A collection of different chromosomal haplotypes is called a familial haplotype. 2.一种用于鉴别CNV微缺失微重复综合征患病胚胎和正常胚胎的家系单体型的构建系统，所述系统包含能够计算处理样本数据的软件、和用于承载上述软件的硬件，其特征在于，2. a construction system for identifying the family haplotype of CNV microdeletion microduplication syndrome diseased embryos and normal embryos, the system comprises the software that can calculate the processing sample data and the hardware for carrying the above-mentioned software, It is characterized in that, 1)所述系统还包含储存有CNV微缺失微重复综合征患者夫妇双方、和至少一名患者亲属进行大规模SNP基因型检测的基因分型数据的硬件；将患者夫妇双方和患者亲属称为参照样本；优选地，所述患者亲属可选自患者的父母、子女、兄弟姐妹，或患有CNV微缺失微重复综合征的患者夫妇流产、引产或活产胎儿组织；所述患者亲属优先选择流产、引产或活产的患病胎儿，也可选择其他患者亲属；更优选地，所述患者亲属可选自同样患有CNV微缺失微重复综合征的亲属，也可选自染色体正常的亲属；1) The system also includes hardware that stores the genotyping data for large-scale SNP genotyping testing performed by both the couple and at least one relative of the patient with CNV microdeletion and microduplication syndrome; Reference sample; preferably, the patient's relatives can be selected from the patient's parents, children, siblings, or the patient's couple with CNV microdeletion microduplication syndrome abortion, induced labor or live birth fetal tissue; the patient's relatives are preferred Aborted, induced or live-born sick fetuses, other relatives of patients can also be selected; more preferably, the relatives of patients can be selected from relatives who also suffer from CNV microdeletion and microduplication syndrome, and can also be selected from relatives with normal chromosomes ; 2)所述软件根据下述规则确定信息SNPs位点：信息SNPs的选择标准为：在CNV微缺失微重复综合征患者中为杂合型，在其配偶中为纯合型，并且在患者亲属中也是纯合型的SNP位点；选择覆盖CNV断裂点、CNV所在染色体和与其相对应的正常的同源染色体上的信息SNPs，染色体每Mb范围内至少选择1个信息SNP；在覆盖CNV断裂点区域，信息SNPs从断裂点上下游1-5Mb范围内选择，优选自1-3Mb范围内选择；2) The software determines the information SNPs loci according to the following rules: the selection criteria of the information SNPs are: heterozygous in CNV microdeletion microduplication syndrome patients, homozygous in their spouses, and in the relatives of the patients. It is also a homozygous SNP site in CNV; select informative SNPs covering the CNV breakpoint, the chromosome where the CNV is located, and its corresponding normal homologous chromosome, and at least 1 informative SNP within each Mb range of the chromosome; In the dot area, the information SNPs are selected from the range of 1-5Mb upstream and downstream of the breakpoint, preferably from the range of 1-3Mb; 3)构建家系单体型：集合步骤2)确定的信息SNPs位点通过家系连锁分析得到覆盖CNV两个断裂点区域、CNV所在整条染色体及其同源染色体的整条染色体的单体型，不同染色体单体型的集合称为家系单体型。3) Constructing the family haplotype: collecting the information SNPs determined in step 2) through family linkage analysis to obtain the haplotype covering the two breakpoint regions of the CNV, the entire chromosome where the CNV is located and the entire chromosome of its homologous chromosome, A collection of different chromosomal haplotypes is called a familial haplotype. 3.一种用于鉴别CNV微缺失微重复综合征患病胚胎和正常胚胎的系统，所述系统包含能够计算处理样本数据的软件、和用于承载上述软件的硬件，其特征在于，3. a system for identifying CNV microdeletion microduplication syndrome diseased embryos and normal embryos, the system comprises the software that can calculate the processing sample data and the hardware for carrying the above-mentioned software, it is characterized in that, 1)所述系统还包含储存有CNV微缺失微重复综合征患者夫妇双方、至少一名患者亲属和CNV微缺失微重复综合征患者夫妇体外受精胚胎进行大规模SNP基因型检测的基因分型数据的硬件；将患者夫妇双方和患者亲属称为参照样本；优选地，所述患者亲属可选自患者的父母、子女、兄弟姐妹，或患有CNV微缺失微重复综合征的患者夫妇流产、引产或活产胎儿组织；所述患者亲属优先选择流产、引产或活产的患病胎儿，也可选择其他患者亲属；更优选地，所述患者亲属可选自同样患有CNV微缺失微重复综合征的亲属，也可选自染色体正常的亲属；1) The system also includes stored genotyping data for large-scale SNP genotyping of both couples of a patient with CNV microdeletion and microduplication syndrome, at least one relative of the patient, and in vitro fertilization embryos of a couple of a patient with CNV microdeletion and microduplication syndrome The hardware of the patient's couple and the patient's relatives are referred to as reference samples; preferably, the patient's relatives can be selected from the patient's parents, children, siblings, or the patient's couple with CNV microdeletion and microduplication syndrome. Abortion, induction of labor Or the tissue of a live-born fetus; the relatives of the patient are preferentially selected for miscarriage, induced labor or live-born diseased fetuses, and other relatives of the patient can also be selected; more preferably, the relatives of the patient can be selected from the same group of patients suffering from CNV microdeletion and microduplication syndrome The relatives of the phenotype can also be selected from relatives with normal chromosomes; 2)所述软件根据下述规则确定信息SNPs位点：信息SNPs的选择标准为：在CNV微缺失微重复综合征患者中为杂合型，在其配偶中为纯合型，并且在患者亲属中也是纯合型的SNP位点；选择覆盖CNV断裂点、CNV所在染色体和与其相对应的正常的同源染色体上的信息SNPs，染色体每Mb范围内至少选择1个信息SNP；在覆盖CNV断裂点区域，信息SNPs从断裂点上下游1-5Mb范围内选择，优选自1-3Mb范围内选择；2) The software determines the information SNPs loci according to the following rules: the selection criteria of the information SNPs are: heterozygous in CNV microdeletion microduplication syndrome patients, homozygous in their spouses, and in the relatives of the patients. It is also a homozygous SNP site in CNV; select informative SNPs covering the CNV breakpoint, the chromosome where the CNV is located, and its corresponding normal homologous chromosome, and at least 1 informative SNP within each Mb range of the chromosome; In the dot area, the information SNPs are selected from the range of 1-5Mb upstream and downstream of the breakpoint, preferably from the range of 1-3Mb; 3)构建家系单体型：集合步骤2)确定的信息SNPs位点通过家系连锁分析得到覆盖CNV两个断裂点区域、CNV所在整条染色体及其同源染色体的整条染色体的单体型，不同染色体单体型的集合称为家系单体型；3) Constructing the family haplotype: collecting the information SNPs determined in step 2) through family linkage analysis to obtain the haplotype covering the two breakpoint regions of the CNV, the entire chromosome where the CNV is located and the entire chromosome of its homologous chromosome, A collection of different chromosomal haplotypes is called a family haplotype; 4)所述软件将待定样本中染色体单体型信息(基因分析数据)和家系单体型中参照样本的单体型信息(基因分型数据)进行比对，着重关注家系单体型中CNV断裂点区域的单体型信息，通过整条染色体的单体型信息判断染色体易位断裂点区域是否发生了同源重组：4) The software compares the haplotype information (gene analysis data) in the undetermined sample with the haplotype information (genotyping data) of the reference sample in the family haplotype, focusing on CNV in the family haplotype The haplotype information of the breakpoint region is used to determine whether homologous recombination has occurred in the chromosomal translocation breakpoint region based on the haplotype information of the entire chromosome: i)当以与CNV微缺失微重复综合征患者具有相同疾病的亲属为参照时：i) When referring to relatives with the same disease as a patient with CNV microdeletion microduplication syndrome: a.若待定样本的染色体对应于家系单体型中CNV断裂点的区域没有发生重组，当待定样本该区域单体型信息和CNV综合征患者以及与患者具有相同疾病亲属的单体型信息一致时，则为CNV综合征患病胚胎；当待定样本该区域单体型信息和参照样本中CNV综合征患者一致，但与患者具有相同疾病亲属的单体型信息不一致时，则为不患CNV综合征的正常胚胎；a. If the chromosome of the undetermined sample does not recombine in the region corresponding to the CNV breakpoint in the family haplotype, when the haplotype information of the undetermined sample is consistent with the haplotype information of the CNV syndrome patient and relatives with the same disease as the patient When the haplotype information of the undetermined sample is consistent with the CNV syndrome patient in the reference sample, but inconsistent with the haplotype information of the patient with the same disease relatives, it is not suffering from CNV Syndromic normal embryos; b.若待定样本的染色体对应于家系单体型中CNV断裂点的区域发生了同源重组，则判断标准与i)a相反；b. If homologous recombination occurs in the chromosome of the undetermined sample corresponding to the CNV breakpoint in the family haplotype, the judgment standard is opposite to i)a; ii)当以CNV正常(不患CNV综合征)的亲属为参照时：ii) When referring to relatives with normal CNV (without CNV syndrome): a.若待定样本的染色体对应于家系单体型中CNV断裂点的区域没有发生重组，当待定样本该区域单体型信息和参照样本中CNV综合征患者以及与CNV正常不患CNV综合征的亲属的单体型信息一致时，则为不患CNV综合征的正常胚胎；当待定样本该区域单体型信息和参照样本中CNV综合征患者一致，但与CNV正常不患CNV综合征的亲属的单体型信息不一致时，则为CNV综合征患病胚胎；a. If there is no recombination in the region of the chromosome of the undetermined sample corresponding to the CNV breakpoint in the family haplotype, when the haplotype information in the region of the undetermined sample and the CNV syndrome patients in the reference sample and those with normal CNV without CNV syndrome When the haplotype information of the relatives is consistent, it is a normal embryo without CNV syndrome; when the haplotype information in the region of the pending sample is consistent with the CNV syndrome patient in the reference sample, but it is with normal CNV relatives without CNV syndrome When the haplotype information is inconsistent, it is a CNV syndrome diseased embryo; b.若待定样本的染色体对应于家系单体型中CNV断裂点的区域发生了同源重组，则判断标准与ii)a相反。b. If homologous recombination occurs in the chromosome of the undetermined sample corresponding to the CNV breakpoint in the family haplotype, the judgment standard is opposite to ii)a. 4.如权利要求1-3任一项所述方法，其特征在于，步骤1)所述大规模SNP基因型检测覆盖23对染色体；大规模SNP基因型检测方法优选基因芯片和基因测序。4. The method of any one of claims 1-3, wherein the large-scale SNP genotype detection in step 1) covers 23 pairs of chromosomes; the large-scale SNP genotype detection method is preferably gene chip and gene sequencing. 5.如权利要求1-3任一项所述方法，其特征在于，CNV微缺失微重复综合征患者夫妇、患者的父母、子女、兄弟姐妹的检测样本来源为体细胞，优选外周血；胎儿样本可来源于流产或引产胎儿的皮肤组织、绒毛组织，也可以来源于活产患病胎儿的外周血组织。5. the method as described in any one of claim 1-3 is characterized in that, the detection sample source of CNV microdeletion microduplication syndrome patient couple, patient's parents, children, siblings is somatic cell, preferably peripheral blood; Samples can be derived from skin tissue, villus tissue from aborted or induced fetuses, or from peripheral blood tissue from live-born sick fetuses. 6.如权利要求1-3任一项所述方法，其特征在于，在覆盖染色体易位断裂点区域，信息SNPs从染色体易位断裂点上下游2-4Mb范围内选择，优选从2Mb范围内选择。6. The method according to any one of claims 1-3, wherein, in the region covering the chromosomal translocation breakpoint, the information SNPs are selected from the range of 2-4Mb upstream and downstream of the chromosomal translocation breakpoint, preferably within the range of 2Mb choose. 7.如权利要求1-6任一项所述方法，其特征在于，步骤2)中染色体每Mb范围内至少选择2、3、4、5、6、7、8、9或10个信息SNPs。7. The method according to any one of claims 1-6, wherein in step 2) at least 2, 3, 4, 5, 6, 7, 8, 9 or 10 informative SNPs are selected within each Mb range of the chromosome . 8.如权利要求3所述方法，其特征在于，胚胎发育至第3-7天时，活检获取1-10个细胞作为步骤1)中所述体外受精胚胎的检测样本；优选来源于胚胎卵裂球活检或囊胚滋养外胚层活检的细胞。8. method as claimed in claim 3, is characterized in that, when embryo develops to the 3rd-7th day, biopsy obtains 1-10 cell as the detection sample of in vitro fertilization embryo described in step 1); Preferably it is derived from embryo cleavage Cells from ball biopsy or blastocyst trophectoderm biopsy. 9.如权利要求8所述方法，其特征在于，将活检获取的细胞裂解，进行全基因组扩增；全基因组扩增方法可选自MDA方法、MALBAC方法、或其他全基因组扩增方法。9. The method of claim 8, wherein the cells obtained from the biopsy are lysed to perform whole genome amplification; the whole genome amplification method can be selected from the MDA method, the MALBAC method, or other whole genome amplification methods.
